<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults - Lam, TBL - 2014 | Cochrane Library</title> <meta content="Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults - Lam, TBL - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004013.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults - Lam, TBL - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004013.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004013.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults" name="citation_title"/> <meta content="Thomas BL Lam" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="thomasbllam@abdn.ac.uk" name="citation_author_email"/> <meta content="Muhammad Imran Omar" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Euan Fisher" name="citation_author"/> <meta content="Academic Urology Unit" name="citation_author_institution"/> <meta content="Katie Gillies" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Sara MacLennan" name="citation_author"/> <meta content="University of Aberdeen" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD004013.pub4" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/09/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004013.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004013.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004013.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Alloys; Anti‐Infective Agents, Urinary [administration &amp; dosage]; Catheter‐Related Infections [etiology, *prevention &amp; control]; Catheters, Indwelling [*adverse effects]; Minocycline [administration &amp; dosage]; Nitrofurazone [administration &amp; dosage]; Randomized Controlled Trials as Topic; Rifampin [administration &amp; dosage]; Silver; Urinary Catheterization [adverse effects, *instrumentation]; Urinary Tract Infections [etiology, *prevention &amp; control]; Urination Disorders [therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004013.pub4&amp;doi=10.1002/14651858.CD004013.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZDBB8PHY";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004013\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004013\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004013.pub4",title:"Types of indwelling urethral catheters for short\\u2010term catheterisation in hospitalised adults",firstPublishedDate:"Sep 23, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Incontinence Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004013.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004013.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004013.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004013.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004013.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004013.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004013.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004013.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004013.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004013.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11280 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004013.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0117"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-sec-0105"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/appendices#CD004013-sec-0126"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/table_n/CD004013StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/table_n/CD004013StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#CD004013-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Thomas BL Lam</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#CD004013-cr-0003">Muhammad Imran Omar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#CD004013-cr-0004">Euan Fisher</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#CD004013-cr-0005">Katie Gillies</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information#CD004013-cr-0006">Sara MacLennan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information/en#CD004013-sec-0136">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 September 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004013.pub4">https://doi.org/10.1002/14651858.CD004013.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004013-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004013-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004013-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004013-abs-0005">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004013-abs-0001" lang="en"> <section id="CD004013-sec-0001"> <h3 class="title" id="CD004013-sec-0001">Background</h3> <p>Urinary tract infection (UTI) is the most common hospital‐acquired infection. The major associated cause is indwelling urethral catheters. Several measures have been introduced to reduce catheter‐associated urinary tract infections (CAUTIs). One of these measures is the introduction of specialised urethral catheters that have been designed to reduce the risk of infection. These include antiseptic‐coated and antimicrobial‐impregnated catheters. </p> </section> <section id="CD004013-sec-0002"> <h3 class="title" id="CD004013-sec-0002">Objectives</h3> <p>The primary objective of this review was to compare the effectiveness of different types of indwelling urethral catheters in reducing the risk of UTI and to assess their impact on other outcomes in adults who require short‐term urethral catheterisation in hospitals. </p> </section> <section id="CD004013-sec-0003"> <h3 class="title" id="CD004013-sec-0003">Search methods</h3> <p>We searched the Cochrane Incontinence Group's Specialised Trials Register, which contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE in process, ClinicalTrials.gov, WHO ICTRP and handsearching of journals and conference proceedings (searched 9 September 2014). We also examined the bibliographies of relevant articles and contacted catheter manufacturer representatives for trials. </p> </section> <section id="CD004013-sec-0004"> <h3 class="title" id="CD004013-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials (RCTs) and quasi‐RCTs comparing types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults. 'Short‐term' is defined as a duration of catheterisation which is intended to be less than or equal to 14 days. </p> </section> <section id="CD004013-sec-0005"> <h3 class="title" id="CD004013-sec-0005">Data collection and analysis</h3> <p>At least two review authors independently screened abstracts, extracted data and assessed risk of bias of the included trials. Any disagreement was resolved by discussion or consultation with a third party. We processed data as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. We assessed the quality of evidence using the GRADE approach. </p> </section> <section id="CD004013-sec-0006"> <h3 class="title" id="CD004013-sec-0006">Main results</h3> <p>Twenty‐six trials met the inclusion criteria involving 12,422 hospitalised adults in 25 parallel group trials, and 27,878 adults in one large cluster‐randomised cross‐over trial. No trials compared one antiseptic catheter versus another, nor an antimicrobial catheter versus another. </p> <p><b>Antiseptic‐coated indwelling urethral catheters versus standard indwelling urethral catheters</b> </p> <p>The primary outcome, symptomatic CAUTI was reported in one large trial with a low risk of bias, comparing silver alloy hydrogel‐coated latex catheter (antiseptic‐coated) against a standard polytetrafluoroethylene (PTFE)‐coated latex catheter (control). The trial used a pragmatic, US Centers for Disease Control and Prevention (CDC)‐based definition for symptomatic CAUTI. For the comparison between silver alloy‐coated catheter versus standard catheter, there was no significant difference in symptomatic CAUTI incidence (RR 0.99, 95% CI 0.85 to 1.16). </p> <p>For secondary outcomes, the included trials reported on two types of antiseptic catheters (coated with either silver oxide or silver alloy). For the outcome of bacteriuria, silver oxide catheters were not associated with any statistically significant reduction (RR 0.90, 95% CI 0.72 to 1.13). These catheters are no longer manufactured. Silver alloy catheters achieved a slight but statistically significant reduction in bacteriuria (RR 0.82, 95% CI 0.73 to 0.92). However, the one large trial with a low risk of bias did not support this finding (RR 0.99, 95% CI 0.85 to 1.16). The randomised cross‐over trial of silver alloy catheters versus standard catheters was excluded from the pooled results because data were not available prior to crossover. The results of this trial showed less bacteriuria in the silver alloy catheter group. </p> <p>For the outcome of discomfort whilst the catheter was in‐situ, fewer patients with silver alloy catheters complained of discomfort compared with standard catheters (RR 0.84, 95% CI 0.74 to 0.96). </p> <p><b>Antimicrobial‐impregnated indwelling urethral catheters versus standard indwelling urethral catheters</b> </p> <p>The primary outcome measure, symptomatic CAUTI was reported in one large trial with a low risk of bias, comparing nitrofurazone‐impregnated silicone catheter (antimicrobial‐impregnated) against a standard PTFE‐coated latex catheter (control). The nitrofurazone catheter achieved a reduction in symptomatic CAUTI incidence which was of borderline statistical significance (RR 0.84, 95% CI 0.71 to 0.99). </p> <p>For secondary outcomes, the included trials reported on two types of antimicrobial catheters (impregnated with either nitrofurazone or minocycline/rifampicin). Antimicrobial‐impregnated catheters, compared with standard catheters, were found to lower the rate of bacteriuria in the antimicrobial group for both minocycline and rifampicin (RR 0.36, 95% CI 0.18 to 0.73), and nitrofurazone (RR 0.73, 95% CI 0.64 to 0.85). The minocycline and rifampicin catheter is no longer manufactured. </p> <p>For the outcome of discomfort whilst the catheter was in‐situ, more patients with nitrofurazone catheters complained of pain whilst the catheter was in‐situ compared with standard catheters (RR 1.26, 95% CI 1.12 to 1.41). For the period after catheter removal, more patients with nitrofurazone catheters complained of pain than standard catheters (RR 1.43, 95% CI 1.30 to 1.57). </p> <p><b>Antimicrobial‐impregnated indwelling urethral catheters versus antiseptic‐coated indwelling urethral catheters</b> </p> <p>One large trial compared antimicrobial‐impregnated (nitrofurazone) catheters versus silver alloy‐coated (antiseptic‐coated) catheters. The results showed people were less likely to have a symptomatic CAUTI with nitrofurazone‐impregnated catheters (228/2153, 10.6%) compared with silver alloy‐coated catheters (263/2097, 12.5%), but this was of borderline statistical significance (RR 0.84, 95% CI 0.71 to 1.00). They did, however, have significantly less bacteriuria (RR 0.78, 95% CI 0.67 to 0.91), </p> <p>While the catheter was in‐situ (RR 1.50, 95% CI 1.32 to 1.70), and on removal (RR 1.32, 95% CI 1.20 to 1.45), nitrofurazone catheters were associated with more discomfort compared with silver‐coated catheters. </p> <p><b>One type of standard indwelling urethral catheter versus another type of standard indwelling urethral catheter</b> </p> <p>None of the trials comparing standard catheters versus other types of standard catheters measured symptomatic CAUTI. In terms of reducing bacteriuria, individual trials were too small to show whether one type of standard catheter was superior to another type. For the outcome of urethral reactions, fully siliconised catheters appeared to be superior to latex‐based catheters. However, the trials involved small numbers of participants. There were no statistically significant differences between the different catheters for all other outcomes. </p> </section> <section id="CD004013-sec-0007"> <h3 class="title" id="CD004013-sec-0007">Authors' conclusions</h3> <p>Silver alloy‐coated catheters were not associated with a statistically significant reduction in symptomatic CAUTI, and are considerably more expensive. Nitrofurazone‐impregnated catheters reduced the risk of symptomatic CAUTI and bacteriuria, although the magnitude of reduction was low and hence may not be clinically important. However, they are more expensive than standard catheters. They are also more likely to cause discomfort than standard catheters. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004013-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004013-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004013-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004013-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004013-abs-0003" lang="en"> <h3>Types of urethral catheters for management of short‐term voiding problems in hospitalised adults </h3> <p><i><b>Background on the condition</b> </i> </p> <p>Urethral catheters are small tubes passed into the bladder via the urethra (outlet for urine). They are often used for a short time after major surgery. Urethral catheters are also used if a person is unable to empty the bladder when they need to (urinary retention). They are also used for monitoring urine output in hospitalised patients. About half of all hospitalised adults who have urethral catheters for longer than a week will get a urinary tract infection (UTI). </p> <p><i><b>The main findings of the review</b> </i> </p> <p>Twenty‐six trials were included in this systematic review involving 12,422 hospitalised adults in 25 parallel group trials, and 27,878 adults in one large cluster‐randomised cross‐over trial.The review of evidence from trials found that although antiseptic‐coated (silver alloy) catheters reduced the number of bacteria in the urine, they did not reduce the number of UTIs caused by the presence of the catheter. Catheters coated with antimicrobials (antibiotics, nitrofurazone) designed to kill or stop the growth of bacteria may reduce both the number of bacteria in the urine as well as number of people having UTI caused by the presence of the catheter. However, the evidence is relatively weak, and any benefit is likely to be small and hence unlikely to be meaningful to either patients or clinicians. </p> <p><i><b>Adverse effects</b> </i> </p> <p>These antibiotic catheters are also more likely to cause discomfort for patients compared with standard catheters, and they are more expensive. </p> <p><i><b>Conclusions</b> </i> </p> <p>The best approaches to reducing the risk of UTI include reducing the numbers of unnecessary catheterisations, or reducing the time period during which the catheter is used by removing it as early as possible. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004013-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004013-sec-0117"></div> <h3 class="title" id="CD004013-sec-0118">Implications for practice</h3> <section id="CD004013-sec-0118"> <p><b>1. Are antiseptic‐coated indwelling urethral catheters better than standard indwelling urethral catheters?</b> </p> <p>The evidence suggests that silver alloy (antiseptic‐coated) catheters do not reduce symptomatic CAUTI, although they appear to reduce bacteruria, in the short‐term catheterised patient. With a few exceptions, the majority of trials dealing with this question were generally of poor quality. </p> <p><b>2. Are antimicrobial‐impregnated indwelling urethral catheters better than standard indwelling urethral catheters?</b> </p> <p>The evidence suggests that antimicrobial‐impregnated catheters do reduce symptomatic CAUTI in hospitalised adults catheterised short‐term, although the margin of benefit appears to be small. They also reduce bacteriuria to a significant degree. However, they are associated with greater patient‐reported discomfort. Whilst these catheters may be cost‐effective, it remains unclear if the marginal benefits are clinically important. Some uncertainties also remain over how beneficial the catheters are beyond one week of catheterisation. </p> <p><b>3. Are antimicrobial‐impregnated indwelling urethral catheters better than antiseptic‐coated indwelling urethral catheters?</b> </p> <p>The data from one well designed study indicated that antimicrobial catheters were more effective in reducing symptomatic CAUTIs than antiseptic‐coated catheters, and in reducing bacteriuria, in hospitalised adults catheterised short‐term. They were also more likely to be more cost‐effective than antiseptic‐coated catheters, although they were associated with more patient‐reported discomfort. </p> <p><b>4. Is one type of standard indwelling urethral catheter better than another type of standard indwelling urethral catheter?</b> </p> <p>No standard catheter was found to be better than another in terms of reducing the risk of bacteriuria in hospitalised adults catheterised short‐term. Siliconised catheters may be less likely to cause urethral side effects in men, but this result should be interpreted with some caution as the trials were small and the outcome definitions and specific catheters compared differed. </p> <p><b>5. Is one type of antiseptic‐coated indwelling urethral catheter better than another type of antiseptic‐coated indwelling urethral catheter?</b> </p> <p>None of the trials included in the review addressed this question.</p> <p><b>6. Is one type of antimicrobial‐impregnated indwelling urethral catheter better than another type of antimicrobial‐impregnated indwelling urethral catheter?</b> </p> <p>None of the trials included in the review addressed this question.</p> </section> <h3 class="title" id="CD004013-sec-0119">Implications for research</h3> <section id="CD004013-sec-0119"> <p>This review found no evidence which supports the use of antiseptic‐coated silver alloy‐coated catheters in reducing symptomatic CAUTI. There was some evidence which suggested that nitrofurazone (antimicrobial‐impregnated) catheters reduced symptomatic CAUTI, but the margin of benefit was small and such catheters were more uncomfortable for patients. </p> <p>However, the following important questions and issues remain unresolved.</p> <section id="CD004013-sec-0120"> <h5 class="title">1. Need for standardised definitions for outcome measures in trials assessing CAUTIs</h5> <p>There is a distinct lack of consensus regarding the choice of outcomes which should be measured in trials, how they should be defined, how they should be measured in terms of the most appropriate measurement tools, time point of outcome measurement, and in their reporting. This leads to difficulty in systematically summarising or pooling the results of different trials, and renders the results of different trials incomparable. Another important knowledge gap is the lack of patient‐centred outcomes, such as satisfaction and discomfort/pain, measured in clinical trials. A core outcome set for trials of interventions for reducing symptomatic CAUTI, which encompasses the most important outcomes and which reflect the interests of patients and clinicians, should be developed (<a href="./references#CD004013-bbs2-0063" title="GargonE , WilliamsonPR , AltmanDG , BlazebyJM , ClarkeM . The COMET Initiative database: progress and activities from 2011 to 2013. Trials2014;10(15):279. [doi: 10.1186/1745‐6215‐15‐279] ">Gargon 2014</a>). </p> </section> <section id="CD004013-sec-0121"> <h5 class="title">2. Valuation of benefit</h5> <p>For the assessment of economic outcomes, there appear to be difficulties in capturing events which accurately reflect the true impact of interventions. For instance, assessment of health‐related QoL impact of experimental interventions, such as urethral catheterisation, which represents only a subsidiary part of overall care of patients undergoing more major intervention (e.g. major surgery), is fraught with difficulties, because any impact of the experimental intervention is likely to be masked by the greater impact of the major intervention. More precise and pragmatic methods of capturing any changes in well‐being specific to the subsidiary intervention, along with the resultant impact on costs, are needed. </p> </section> <section id="CD004013-sec-0122"> <h5 class="title">3. Further exploration of antimicrobial devices</h5> <p>The exploration of different materials and antimicrobial agents constituting the catheter, or different ways or strategies of inhibiting the formation of catheter biofilms, remains appealing and deserves further research. New catheter materials are being introduced all the time, along with new ways of inhibiting bacterial biofilm formation within the catheter surface, such as the incorporation of drug‐eluting materials. </p> </section> <section id="CD004013-sec-0123"> <h5 class="title">4. Alternative interventions to reduce CAUTI</h5> <p>Whilst much emphasis has been placed on innovative catheter designs (e.g. coating or impregnation with antiseptic or antimicrobial compounds), more pragmatic and intuitive strategies, based on minimising the incidence of catheterisations, shortening catheter duration, and using alternative techniques (e.g. intermittent self catheterisation catheters), warrant further research. </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004013-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004013-sec-0015"></div> <div class="table" id="CD004013-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antispetic‐coated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antiseptic‐coated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> antiseptic‐coated catheter versus standard catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antiseptic‐coated catheter versus standard catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ silver alloy versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4241<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ silver alloy versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4241<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary sepsis</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ‐ silver oxide versus standard</b> <br/> Number with pain with catheter in place </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ‐ silver alloy versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3718<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1,2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Only one trial.<br/> <sup>2</sup> Not applicable as there is only one trial.<br/> <sup>3</sup> 95% confidence interval is wide (0.83 to 1.42)<br/> <sup>4</sup> Sequence generation and allocation concealment unclear.<br/> <sup>5</sup> GRADE‐specific outcome was patient reported discomfort whilst trial reported patient reported pain.<br/> <sup>6</sup> 95% confidence interval is very wide (0.48 to 4.27) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004013-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antimicrobial‐impregnated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> antimicrobial‐impregnated catheter versus standard catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antimicrobial‐impregnated catheter versus standard catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ nitrofurazone versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4297<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ nitrofurazone versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4297<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards the antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ ‐ nitrofurazone versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3768<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Not applicable because there was only one trial. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004013-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> antimicrobial‐impregnated catheter versus antiseptic‐coated catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ antibiotic versus silver alloy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.84</b> <br/> (0.71 to 1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4250<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>125 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> <br/> (89 to 125) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards the antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ antibiotic versus silver alloy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.64</b> <br/> (0.48 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4250<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b> <br/> (24 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Patient discomfort whilst catheter is in situ</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.5</b> <br/> (1.32 to 1.7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3708<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>176 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>264 per 1000</b> <br/> (232 to 299) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Not applicable because there was only one trial.<br/> <sup>2</sup> 95% Confidence interval is wide (0.71 to 1.00). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004013-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">One type of standard catheter versus another standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>One type of standard catheter versus another standard catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> one type of standard catheter versus another standard catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> One type of standard catheter versus another standard catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ nitrofurazone versus standard</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards the antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ</b> <br/> Number with burning sensation in urethra ‐ Silicone versus non‐silicone </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ nitrofurazone versus standard</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Did not specify the method of sequence generation and allocation concealment.<br/> <sup>2</sup> Only one trial.<br/> <sup>3</sup> Burning sensation in urethra is used as a proxy of patient discomfort.<br/> <sup>4</sup> Only one trial. Funnel plot not applicable. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004013-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004013-sec-0016"></div> <section id="CD004013-sec-0017"> <h3 class="title" id="CD004013-sec-0017">Description of the condition</h3> <p>Urinary tract infection (UTI) is the most common hospital‐acquired infection, accounting for between 20% and 40% of cases (<a href="./references#CD004013-bbs2-0061" title="EmmersonAM , EnstoneJE , GriffinM , KelseyMC , SmythET . The Second National Prevalence Survey of infection in hospitals‐overview of the results. Journal of Hospital Infection1996;32(3):175‐90. ">Emmerson 1996</a>; <a href="./references#CD004013-bbs2-0070" title="HaleyRW , HootonTM , CulverDH , StanleyRC , EmoriTG , HardisonCD , et al. Nosocomial infections in US hospitals, 1975–1976: estimated frequency by selected characteristics of patients. American Journal of Medicine1981;70(4):947–59. ">Haley 1981</a>; <a href="./references#CD004013-bbs2-0093" title="SmythET , McIlvennyG , EnstoneJE , EmmersonAM , HumphreysH , FitzpatrickF , et al. Four country healthcare associated infection prevalence survey 2006: overview of the results. Journal of Hospital Infection2008;69(3):230‐48. ">Smyth 2008</a>). Up to 80% of these UTIs occurring in hospitals can be attributed to the use of indwelling urethral catheters (<a href="./references#CD004013-bbs2-0058" title="BryanCS , ReynoldsKL . Hospital‐acquired bacteremic urinary tract infection: epidemiology and outcome. Journal of Urology1984;132(3):494‐8. ">Bryan 1984</a>; <a href="./references#CD004013-bbs2-0093" title="SmythET , McIlvennyG , EnstoneJE , EmmersonAM , HumphreysH , FitzpatrickF , et al. Four country healthcare associated infection prevalence survey 2006: overview of the results. Journal of Hospital Infection2008;69(3):230‐48. ">Smyth 2008</a>; <a href="./references#CD004013-bbs2-0096" title="TurckM , StammW . Nosocomial infection of the urinary tract. American Journal of Medicine1981;70(3):651‐4. ">Turck 1981</a>). Catheter‐associated UTIs (CAUTIs) account for significant morbidity, with symptoms such as dysuria, urgency, frequency, haematuria, fever or bladder pain, or more serious complications such as bloodstream infection (<a href="./references#CD004013-bbs2-0058" title="BryanCS , ReynoldsKL . Hospital‐acquired bacteremic urinary tract infection: epidemiology and outcome. Journal of Urology1984;132(3):494‐8. ">Bryan 1984</a>; <a href="./references#CD004013-bbs2-0075" title="KriegerJN , KaiserDL , WenzelRP . Urinary tract etiology of bloodstream infections in hospitalized patients. Journal of Infectious Diseases1983;148(1):57‐62. ">Krieger 1983</a>). In addition, healthcare costs increase by prolonging hospital stay, and this can adversely affect patients’ health‐related quality of life (<a href="./references#CD004013-bbs2-0091" title="SaintS , VeenstraDL , SullivanSD , ChenowethC , FendrickAM . The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Archives of Internal Medicine2000;160(17):2670‐5. ">Saint 2000</a>; <a href="./references#CD004013-bbs2-0095" title="TambyahPA , KnasinskiV , MakiDG . The direct costs of nosocomial catheter‐associated urinary tract infection in the era of managed care. Infection Control and Hospital Epidemiology2002;23(1):27‐31. ">Tambyah 2002</a>). </p> <p>Urethral catheters are one of the most commonly applied medical devices. The indications for short‐term catheterisation include monitoring of urine output during the perioperative stage or in acutely unwell patients, as part of a urological procedure, or the treatment of patients with acute urinary retention. The prevalence of catheterisation is high, with up to a quarter of patients admitted to hospital requiring urethral catheterisation at some stage during their stay (<a href="./references#CD004013-bbs2-0066" title="GouldCV , UmscheidCA , AgarwalRK , KuntzG , PeguesDA . Guideline for prevention of catheter‐associated urinary tract infections 2009. Infection Control and Hospital Epidemiology2010;31(4):319‐26. ">Gould 2010</a>; <a href="./references#CD004013-bbs2-0070" title="HaleyRW , HootonTM , CulverDH , StanleyRC , EmoriTG , HardisonCD , et al. Nosocomial infections in US hospitals, 1975–1976: estimated frequency by selected characteristics of patients. American Journal of Medicine1981;70(4):947–59. ">Haley 1981</a>; <a href="./references#CD004013-bbs2-0098" title="WeinsteinJW , MazonD , PantelickE , Reagan‐CirincioneP , DembryLM , HierholzerWJJr . A decade of prevalence surveys in a tertiary‐care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infection Control and Hospital Epidemiology1999;20(8):543‐8. ">Weinstein 1999</a>). For patients with urethral catheters, there is a cumulative daily risk of 5% of developing bacteriuria (<a href="./references#CD004013-bbs2-0070" title="HaleyRW , HootonTM , CulverDH , StanleyRC , EmoriTG , HardisonCD , et al. Nosocomial infections in US hospitals, 1975–1976: estimated frequency by selected characteristics of patients. American Journal of Medicine1981;70(4):947–59. ">Haley 1981</a>) (i.e. presence of bacteria in the urine), with the risk increasing to 35% and 70%, after 7 and 14 days of indwelling catheterisation, respectively. Whilst bacteriuria does not normally cause symptoms (i.e. asymptomatic bacteriuria), it does increase the risk of developing a symptomatic UTI; it has been estimated that symptomatic UTI occurs in 20% of patients with bacteriuria (<a href="./references#CD004013-bbs2-0064" title="GaribaldiRA , MooneyBR , EpsteinBJ . An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter‐associated urinary tract infection. Infection Control1982;3(6):466‐70. ">Garibaldi 1982</a>; <a href="./references#CD004013-bbs2-0071" title="HartsteinAI , GarberSB , WardTT , JonesSR , MorthlandVH . Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients. Infection Control1981;2(5):380‐6. ">Hartstein 1981</a>). It is also associated with a small risk of bloodstream infection (&lt; 1%) (<a href="./references#CD004013-bbs2-0058" title="BryanCS , ReynoldsKL . Hospital‐acquired bacteremic urinary tract infection: epidemiology and outcome. Journal of Urology1984;132(3):494‐8. ">Bryan 1984</a>; <a href="./references#CD004013-bbs2-0075" title="KriegerJN , KaiserDL , WenzelRP . Urinary tract etiology of bloodstream infections in hospitalized patients. Journal of Infectious Diseases1983;148(1):57‐62. ">Krieger 1983</a>); whilst this risk is relatively low, bloodstream infection is associated with a high mortality rate of approximately 30%. The presence of bacteriuria in hospital patients with an indwelling catheter is also a potential source of cross‐infection, particularly in critical care units, with an estimated risk per episode of 15% (<a href="./references#CD004013-bbs2-0074" title="JohnsonJR , KuskowskiMA , WiltTJ . Systematic review: antimicrobial urinary catheters to prevent catheter‐associated urinary tract infection in hospitalized patients. Annals of Internal Medicine2006;144(2):116‐26. ">Johnson 2006</a>). Other factors that increase the risk of infection include female gender, older age, impaired immunity, severity of illness (<a href="./references#CD004013-bbs2-0094" title="StammWE . Urinary tract infection. In: BennettJV , BrachmandPS editor(s). Hospital Infections. 4th Edition. Philadelphia: Lippincott‐Raven, 1998:477‐85. ">Stamm 1998</a>), and care process factors, such as lack of antibiotic use, longer duration of catheterisation, catheter insertion or maintenance by poorly trained personnel, and deviation from catheter care protocols (<a href="./references#CD004013-bbs2-0059" title="Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee. Guideline for Prevention of Catheter‐Associated Urinary Tract Infections. www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf(accessed July 2011). ">CDC 2009</a>). </p> <p>In terms of the microbiology of UTIs, infections associated with short‐term catheterisation typically involve a single organism, in contrast with long‐term catheterisation, where polymicrobial infection is frequent (<a href="./references#CD004013-bbs2-0059" title="Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee. Guideline for Prevention of Catheter‐Associated Urinary Tract Infections. www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf(accessed July 2011). ">CDC 2009</a>). Although a variety of micro‐organisms may be associated with CAUTI, the commonest pathogens are enteric Gram negative bacilli (<a href="./references#CD004013-bbs2-0092" title="ShumanEK , ChenowethCE . Recognition and prevention of healthcare‐associated urinary tract infections in the intensive care unit. Critical Care Medicine2010;38(8 Suppl):S373‐9. ">Shuman 2010</a>) <i>Escherichia coli</i> (<i>E. Coli</i> ) is the most frequently isolated single species, but other species such as <i>Klebsiella</i> spp., <i>Proteus</i> spp<i>.</i> and <i>Enterobacter</i> spp. are also commonly identified. <i>Enterococci</i> , <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i> ) and <i>Candida</i> spp. are also important causes of CAUTI, particularly in patients within critical care settings. Forty <i>Staphylococci</i> and other Gram‐negative bacilli are isolated less frequently (<a href="./references#CD004013-bbs2-0059" title="Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee. Guideline for Prevention of Catheter‐Associated Urinary Tract Infections. www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf(accessed July 2011). ">CDC 2009</a>). </p> <p>The criterion for diagnosis of a symptomatic CAUTI varies significantly in the literature. However, efforts have been made by healthcare organisations, such as the US Centers for Disease Control and Prevention (CDC) to standardise definitions, based on different scenarios (e.g. UTI in presence of a urethral catheter, symptomatic UTI, etc.) (<a href="./references#CD004013-bbs2-0059" title="Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee. Guideline for Prevention of Catheter‐Associated Urinary Tract Infections. www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf(accessed July 2011). ">CDC 2009</a>). It is worthwhile noting that the CDC’s definitions for UTI have undergone several revisions in the past two decades. In line with CDC definitions, past and present, which reflect clinically relevant outcomes, for purposes of this review, a positive urine culture reported without any consideration for patient symptoms is defined as bacteriuria rather than a UTI. </p> <p>Several strategies and policies aimed at reducing CAUTI have been introduced. These can be summarised as follows: (1) education of patients, their caregivers and healthcare personnel, in terms of hand hygiene and steps in preventing spread of infection; (2) reduction in the prevalence of catheterisation by assessing the need for catheterisation, and restricting the intervention to those who have no other alternative of achieving bladder drainage; (3) use of aseptic technique for catheter insertion; (4) use of antibiotic prophylaxis in selected high risk groups at insertion based on local antibiotic prescribing policies; (5) maintenance of a sterile, closed drainage system by obtaining urine specimens from the sampling port, positioning of drainage bag above floor level and below bladder level; (6) frequent emptying of drainage bag to maintain urine flow and prevent reflux, and daily washing of urethral meatus; (7) minimising the duration of catheterisation by regularly reviewing the need for catheterisation, and by aiming for early removal of catheter; and (8) coating or impregnation of catheter surface with antiseptic or antimicrobial substances (<a href="./references#CD004013-bbs2-0101" title="BrosnahanJ , JullA , TracyC . Types of urethral catheters for management of short‐term voiding problems in hospitalised adults. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD004013.pub2] ">Brosnahan 2004</a>; <a href="./references#CD004013-bbs2-0081" title="ParkerD , CallanL , HarwoodJ , ThompsonDL , WildeM , GrayM . Nursing interventions to reduce the risk of catheter‐associated urinary tract infection. Part 1: Catheter selection. Journal of Wound, Ostomy and Continence Nursing2009;36(1):23‐34. ">Parker 2009</a>; <a href="./references#CD004013-bbs2-0086" title="PrattRJ , PelloweCM , WilsonJA , LovedayHP , HarperPJ , JonesSR , et al. epic2: National evidence‐based guidelines for preventing healthcare‐associated infections in NHS hospitals in England. Journal of Hospital Infection2007;65 Suppl 1:S1‐S64. ">Pratt 2007</a>; <a href="./references#CD004013-bbs2-0102" title="SchummK , LamTBL . Types of urethral catheters for management of short‐term voiding problems in hospitalised adults. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD004013.pub3; CD004013] ">Schumm 2008</a>; <a href="./references#CD004013-bbs2-0099" title="WillsonM , WildeM , WebbML , ThompsonD , ParkerD , HarwoodJ , et al. Nursing interventions to reduce the risk of catheter‐associated urinary tract infection: part 2: staff education, monitoring, and care techniques. Journal of Wound, Ostomy, and Continence Nursing2009;36(2):137‐54. ">Willson 2009</a>). </p> </section> <section id="CD004013-sec-0018"> <h3 class="title" id="CD004013-sec-0018">Description of the intervention</h3> <p>Currently, there are many types of catheters available. Standard indwelling catheters are made from a variety of materials including: polyvinyl chlorine, plastic, plain latex, polytetrafluoroethylene (PTFE)‐coated latex, hydrogel‐coated latex, silicone elastomer, pure silicone hydrogel and polymer hydromer (<a href="./references#CD004013-bbs2-0085" title="PomfretI . Catheter care in the community. Nursing Standard2000;14(27):46‐53. ">Pomfret 2000</a>; <a href="./references#CD004013-bbs2-0089" title="RobinsonJ . Urethral catheter selection. Nursing Standard2001;15(25):39‐42. ">Robinson 2001</a>). Specialised urethral catheters have been developed specifically to reduce the risk of infection. A common approach is to coat the catheter with antiseptic or antimicrobial agents either on the outer surface, the lumen, or both (<a href="./references#CD004013-bbs2-0090" title="SaintS , ElmoreJG , SullivanSD , EmersonSS , KoepsellTD . The efficacy of silver alloy‐coated urinary catheters in preventing urinary tract infection: A meta‐analysis. American Journal of Medicine1998;105:236‐41. [MEDLINE: 99086386] ">Saint 1998</a>), or impregnated into the catheter material. </p> </section> <section id="CD004013-sec-0019"> <h3 class="title" id="CD004013-sec-0019">How the intervention might work</h3> <p>Antiseptic agents are substances which kill bacteria and other micro‐organisms. The most common antiseptic agent used is silver. Silver has long been recognised as an antiseptic agent active against a variety of uropathogens through multiple mechanisms of action (<a href="./references#CD004013-bbs2-0062" title="FrankenA , van denBoschEEM , Crespo‐BielO , LoontjensJA , DiasAA . Anti‐microbial coatings for urological applications. European Cells and Materials2007;14 Suppl 3:130. ">Franken 2007</a>). Silver exposure results in limited toxicity to human tissues (<a href="./references#CD004013-bbs2-0065" title="GoshegerG , HardesJ , AhrensH , StreitburgerA , BuergerH , ErrenM , et al. Silver‐coated megaendoprostheses in a rabbit model‐an analysis of the infection rate and toxicological side effects. Biomaterials2004;25(24):5547‐56. ">Gosheger 2004</a>) and does not appear to induce microbial resistance (<a href="./references#CD004013-bbs2-0082" title="PercivalSL , BowlerPG , RussellD . Bacterial resistance to silver in wound care. Journal of Hospital Infection2005;60(1):1‐7. ">Percival 2005</a>). Two types of silver‐based agents have been used to coat urethral catheters: silver alloy and silver oxide (<a href="./references#CD004013-bbs2-0090" title="SaintS , ElmoreJG , SullivanSD , EmersonSS , KoepsellTD . The efficacy of silver alloy‐coated urinary catheters in preventing urinary tract infection: A meta‐analysis. American Journal of Medicine1998;105:236‐41. [MEDLINE: 99086386] ">Saint 1998</a>). </p> <p>Antibiotics are antimicrobial drugs which can either kill bacteria or inhibit their growth to stop or prevent infections. Antimicrobial‐impregnated catheters have also been developed using various types of antibiotics active against expected uropathogens. These antimicrobial agents are impregnated into the external and internal luminal catheter surfaces, and elute over time into the external surface‐urethral mucosa and internal lumen–urinary boundaries (<a href="./references#CD004013-bbs2-0068" title="GuayDR . An update on the role of nitrofurans in the management of urinary tract infections. Drugs2001;61(3):353‐64. ">Guay 2001</a>). </p> </section> <section id="CD004013-sec-0020"> <h3 class="title" id="CD004013-sec-0020">Why it is important to do this review</h3> <p>Several systematic reviews have investigated the effectiveness of antiseptic and antimicrobial catheters in reducing CAUTIs (<a href="./references#CD004013-bbs2-0060" title="DrekonjaDM , KuskowskiMA , WiltTJ , JohnsonJR . Antimicrobial urinary catheters: a systematic review. Expert Review of Medical Devices2008;5(4):495‐506. ">Drekonja 2008</a>; <a href="./references#CD004013-bbs2-0074" title="JohnsonJR , KuskowskiMA , WiltTJ . Systematic review: antimicrobial urinary catheters to prevent catheter‐associated urinary tract infection in hospitalized patients. Annals of Internal Medicine2006;144(2):116‐26. ">Johnson 2006</a>; <a href="./references#CD004013-bbs2-0090" title="SaintS , ElmoreJG , SullivanSD , EmersonSS , KoepsellTD . The efficacy of silver alloy‐coated urinary catheters in preventing urinary tract infection: A meta‐analysis. American Journal of Medicine1998;105:236‐41. [MEDLINE: 99086386] ">Saint 1998</a>; <a href="./references#CD004013-bbs2-0102" title="SchummK , LamTBL . Types of urethral catheters for management of short‐term voiding problems in hospitalised adults. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD004013.pub3; CD004013] ">Schumm 2008</a>), including the previous update of the present review (<a href="./references#CD004013-bbs2-0092" title="ShumanEK , ChenowethCE . Recognition and prevention of healthcare‐associated urinary tract infections in the intensive care unit. Critical Care Medicine2010;38(8 Suppl):S373‐9. ">Shuman 2010</a>). The results of these reviews suggest that silver alloy‐coated catheters and nitrofurazone‐impregnated catheters may reduce the incidence of bacteriuria in hospitalised patients catheterised for less than two weeks in comparison with standard catheters. The magnitude of relative risk reduction varied in each of the analyses due to different inclusion criteria, ranging from 16% to 48%. However, the far majority of included studies in those reviews defined CAUTI based solely on microbiological identification of bacteriuria without any patient‐driven or clinician‐defined contribution to the primary outcomes used. Since the last Cochrane review update, the results of a large RCT which compared silver alloy‐coated and nitrofurazone‐impregnated short‐term urethral catheters versus standard catheters and which assessed clinically relevant outcomes, have been published (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>). </p> <p>The aim of this review was to investigate the effects of these specialised catheters in comparison with standard ones in reducing the incidence of symptomatic CAUTI in hospitalised patients requiring short‐term catheterisation, but also taking into account other factors, such as ease of use, comfort and cost that may influence decision‐making regarding these catheters. For the purpose of this review, short‐term was defined as up to and including 14 days, or other temporary short‐term use as defined by the trialists. </p> <p>The following are relevant Cochrane reviews that may be of interest to the reader.</p> <p> <ul id="CD004013-list-0001"> <li> <p>Antibiotic policies for short‐term catheter bladder drainage in adults (<a href="./references#CD004013-bbs2-0078" title="Niël‐WeiseBS , van denBroekPJ . Antibiotic policies for short‐term catheter bladder drainage in adults. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD005428; CD005428] ">Niël‐Weise 2005a</a>). </p> </li> <li> <p>Antibiotic prophylaxis for short‐term catheter bladder drainage in adults (<a href="./references#CD004013-bbs2-0076" title="LusardiG , LippA , ShawC . Antibiotic prophylaxis for short‐term catheter bladder drainage in adults. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD005428.pub2; CD005428] ">Lusardi 2013</a>). </p> </li> <li> <p>Short‐term urethral catheter policies following urogenital surgery in adults (<a href="./references#CD004013-bbs2-0083" title="PhippsS , LimYN , McClintonS , BarryC , RaneA , N'DowJMO . Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD004374.pub2; CD004374] ">Phipps 2006</a>). </p> </li> <li> <p>Strategies for the removal of short‐term indwelling urethral catheters in adults (<a href="./references#CD004013-bbs2-0067" title="GriffithsR , FernandezR . Strategies for the removal of short‐term indwelling urethral catheters in adults. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD004011.pub3; CD004011] ">Griffiths 2007</a>). </p> </li> <li> <p>Urethral catheter policies for short‐term bladder drainage in adults (<a href="./references#CD004013-bbs2-0079" title="Niël‐WeiseBS , van denBroekPJ . Urinary catheter policies for short‐term bladder drainage in adults. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD004203.pub2; CD004203] ">Niël‐Weise 2005b</a>). </p> </li> </ul> </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004013-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004013-sec-0021"></div> <p>The primary objective of this review was to compare the effectiveness of different types of indwelling urethral catheters in reducing the risk of UTI and to assess their impact on other outcomes in adults who require short‐term urethral catheterisation in hospitals. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004013-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004013-sec-0022"></div> <section id="CD004013-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004013-sec-0024"> <h4 class="title">Types of studies</h4> <p>All RCTs and quasi‐RCTs comparing types of indwelling urethral catheters for short‐term catheterisation in hospitalised adults. Short‐term is defined as duration of catheterisation which is intended to be less than or equal to 14 days. </p> </section> <section id="CD004013-sec-0025"> <h4 class="title">Types of participants</h4> <p>Hospitalised adults (patients admitted to an adult hospital) with an indwelling urethral catheter of short‐term duration (less than or equal to 14 days duration, or other temporary short‐term use as defined by the trialists). </p> <section id="CD004013-sec-0026"> <h5 class="title">Exclusions</h5> <p> <ul id="CD004013-list-0002"> <li> <p>Children</p> </li> <li> <p>Residential care facilities</p> </li> <li> <p>Adult patients with chronic/long‐term catheterisation for more than 14 days</p> </li> <li> <p>Patients anticipated as needing a catheter in the long‐term</p> </li> <li> <p>Patients admitted with an indwelling catheter</p> </li> <li> <p>Patients with suprapubic urethral catheters</p> </li> <li> <p>Patients with pre‐existing UTIs</p> </li> </ul> </p> </section> </section> <section id="CD004013-sec-0027"> <h4 class="title">Types of interventions</h4> <p>Different types of indwelling urethral catheters:</p> <p> <ul id="CD004013-list-0003"> <li> <p>antiseptic‐impregnated indwelling urethral catheters;</p> </li> <li> <p>antimicrobial‐impregnated indwelling urethral catheters;</p> </li> <li> <p>standard indwelling urethral catheters (defined as catheters that are not impregnated with antiseptics or antimicrobial) </p> </li> </ul> </p> <p>We wished to make the following comparisons:<br/> <br/> 1. Antiseptic‐coated indwelling urethral catheters versus standard indwelling urethral catheters;<br/> 2. Antimicrobial‐impregnated indwelling urethral catheters versus standard indwelling urethral catheters;<br/> 3. Antimicrobial‐impregnated indwelling urethral catheters versus antiseptic‐coated indwelling urethral catheters;<br/> 4. One type of standard indwelling urethral catheter versus another type of standard indwelling urethral catheter;<br/> 5. One type of antiseptic‐coated indwelling urethral catheter versus another type of antiseptic‐coated indwelling urethral catheter;<br/> 6. One type of antimicrobial‐impregnated indwelling urethral catheter versus another type of antimicrobial‐impregnated indwelling urethral catheter </p> </section> <section id="CD004013-sec-0028"> <h4 class="title">Types of outcome measures</h4> <section id="CD004013-sec-0029"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome of interest was the number of people with symptomatic CAUTI.</p> </section> <section id="CD004013-sec-0030"> <h5 class="title">Secondary outcomes</h5> <p><b>Microbiological</b> </p> <p> <ul id="CD004013-list-0004"> <li> <p>Bacteriuria (defined by trialists)</p> </li> <li> <p>Bacterial resistance</p> </li> </ul> </p> <p><b>Patient‐reported</b> </p> <p> <ul id="CD004013-list-0005"> <li> <p>Patient discomfort</p> </li> <li> <p>Patient satisfaction</p> </li> </ul> </p> <p><b>Clinician‐reported</b> </p> <p> <ul id="CD004013-list-0006"> <li> <p>Length of time catheters used</p> </li> </ul> </p> <p><b>Quality of life</b> </p> <p> <ul id="CD004013-list-0007"> <li> <p>Generic QoL measures (e.g. SF 36, <a href="./references#CD004013-bbs2-0097" title="WareJE , SnowKK , KosinskiM , GandekB . The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. [MEDLINE: 92278120] ">Ware 1992</a>) </p> </li> <li> <p>Psychological outcome measures (e.g. HADS, <a href="./references#CD004013-bbs2-0100" title="ZigmondAS , SnaithRP . The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica1983;67(6):361‐70. ">Zigmond 1983</a>) </p> </li> </ul> </p> <p><b>Complications/adverse effects</b> </p> <p> <ul id="CD004013-list-0008"> <li> <p>Septicaemia</p> </li> <li> <p>Death due to septicaemia</p> </li> <li> <p>Allergic reactions to catheter materials</p> </li> <li> <p>Other adverse effects of intervention (as described by trialists)</p> </li> </ul> </p> <p><b>Co‐interventions</b> </p> <p> <ul id="CD004013-list-0009"> <li> <p>Use of prophylactic antibiotics</p> </li> <li> <p>Use of rescue antibiotics</p> </li> </ul> </p> <p><b>Economic outcomes</b> </p> <p> <ul id="CD004013-list-0010"> <li> <p>cost‐effectiveness</p> </li> </ul> </p> <p><b>Other outcomes</b> </p> <p>Any other non‐pre‐specified outcomes judged to be important when performing the review.</p> <p>We classified the primary and secondary outcomes above as critical, important or not important from patients' perspective for decision‐making. The GRADE working group strongly recommends including up to seven critical outcomes in a systematic review to be assessed via the GRADE approach (<a href="./references#CD004013-bbs2-0069" title="Guyatt 2011GuyattGH , OxmanAD , SchunemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articlesin the Journal of Clinical Epidemiology. Journal of ClinicalEpidemiology2011;64(4):380–2. ">Guyatt 2011</a>). </p> <p>We contacted content experts to identify outcomes of importance to patients undergoing short‐term urethral catheterisation that could be included in a Cochrane systematic review. The content experts included clinicians, nurses, and a health economist. Subsequently, through the Urological Cancer Charity (UCAN), we identified five individuals who had undergone urethral catheterisation and invited them to take part in a group discussion to identify important outcomes from their perspective. The participants were not aware of the views of the content experts. On the whole, the participants were in agreement with the content experts regarding the key outcomes of importance. For example, they suggested that infections and discomfort were certainly important from their point of view. However, they also highlighted other outcomes as being meaningful and important such as length of hospital stay and the duration of catheterisation. Interestingly, participants also raised issues around being catheterised and the impact on self esteem and ability to wear clothes comfortably (<a href="./references#CD004013-bbs2-0080" title="OmarMI , LamT , MacLennan . Critical outcomes in a Cochrane Systematic Review: patients’ perspective. Cochrane Database Syst Rev Suppl 1‐212. 2013:2. [DOI:10.1002/14651858.CD201300] ">Omar 2013</a>). We selected the following critical outcomes to assess the quality of evidence in this systematic review, as suggested by patients and content experts. </p> <p> <ul id="CD004013-list-0011"> <li> <p>Symptomatic CAUTI.</p> </li> <li> <p>Patient discomfort whilst catheter is in‐situ.</p> </li> <li> <p>Bacterial resistance towards the antimicrobial agent.</p> </li> <li> <p>Septicaemia.</p> </li> </ul> </p> </section> </section> </section> <section id="CD004013-sec-0031"> <h3 class="title">Search methods for identification of studies</h3> <p>We did not impose any language or other restrictions on any of the searches detailed below. </p> <section id="CD004013-sec-0032"> <h4 class="title">Electronic searches</h4> <p>This review has drawn on the search strategy developed for the Cochrane Incontinence Group. Relevant trials were identified from the Cochrane Incontinence Group Specialised Register of controlled trials. For more details of the search methods used to build the Specialised Register please see the Group's <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/INCONT/frame.html" target="_blank">module</a> in <i>The Cochrane Library</i>. The Register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and MEDLINE in process, ClinicalTrials.gov, WHO ICTRP and handsearching of journals and conference proceedings. Most of the trials in the Cochrane Incontinence Group Specialised Register are also contained in CENTRAL. The date of the last search was: 9 September 2014. (Please note: The first version of this review searched the Cochrane Renal Group Specialised Register (searched February 2003)). </p> <p>The terms used to search the Cochrane Incontinence Group Specialised Register are given in <a href="./appendices#CD004013-sec-0127">Appendix 1</a>. </p> </section> <section id="CD004013-sec-0033"> <h4 class="title">Searching other resources</h4> <p>We searched the bibliographies of relevant articles. We also contacted catheter manufacturer representatives, however we did not identify any further trials for inclusion. </p> </section> </section> <section id="CD004013-sec-0034"> <h3 class="title" id="CD004013-sec-0034">Data collection and analysis</h3> <section id="CD004013-sec-0035"> <h4 class="title">Selection of studies</h4> <p>Three review authors (TL, MO or EF) independently assessed all titles and abstracts identified by the search. Where there was the possibility that the study might be included, the full paper was obtained. We resolved any disagreements through discussion. Another review author was available to resolve any disagreements related to study inclusion. We excluded studies that were not randomised or quasi‐randomised trials comparing types of indwelling urethral catheters in hospitalised adults. </p> </section> <section id="CD004013-sec-0036"> <h4 class="title">Data extraction and management</h4> <p>One review author extracted trial data using a standardised form and this was independently verified by a second review author. Any disagreement which arose was resolved either by discussion or by arbitration with a third party. Where data in trials were not fully reported, clarification was sought directly from the trialists. We entered the extracted data into Review Manager software (<a href="./references#CD004013-bbs2-0088" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). We processed all data from included trials according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD004013-sec-0037"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>At least two review authors (TL, MO and EF) investigated the included trials for risk of bias using the Cochrane 'Risk of bias' assessment tool (<a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed a range of specific issues, including: </p> <p> <ul id="CD004013-list-0012"> <li> <p>random sequence generation;</p> </li> <li> <p>level of concealment of random allocation;</p> </li> <li> <p>participant/therapist blinding;</p> </li> <li> <p>outcome assessor blinding;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>any other potential sources of bias.</p> </li> </ul> </p> <p>We resolved disagreements which arose either by discussion or by consultation with a third party. </p> </section> <section id="CD004013-sec-0038"> <h4 class="title">Measures of treatment effect</h4> <p>We processed included trial data as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). When appropriate, we undertook meta‐analysis. We categorised comparisons by type of intervention catheter. We performed sensitivity analyses that indicated that the results of silver oxide versus standard catheters and silver alloy versus standard catheters should not be combined. However, we combined data from different types of standard catheters for comparison with antimicrobial‐impregnated and antiseptic‐coated catheters. Where possible, we performed subgroup analyses, comparing outcomes by gender and according to whether the participants were receiving systemic antibiotics. </p> <p>For categorical outcomes we related the numbers reporting an outcome to the numbers at risk in each group to derive a relative risk. For continuous variables we used means and standard deviations to derive a mean difference (MD). We used a fixed‐effect model to calculate the pooled relative risks, MD and their 95% confidence intervals (CIs). However, we also checked results using a random‐effects model. We compared trials to assess and investigate the likelihood of important clinical heterogeneity. Where we observed significant statistical heterogeneity, we offered an explanation in the text. We could not apply publication bias using a funnel plot as there were fewer than 10 trials in the meta‐analysis. </p> </section> <section id="CD004013-sec-0039"> <h4 class="title">Unit of analysis issues</h4> <p>The primary analysis was per patient randomised.</p> </section> <section id="CD004013-sec-0040"> <h4 class="title">Dealing with missing data</h4> <p>As far as possible, we analysed data on an intention‐to‐treat basis, meaning that analysis of patients was according to the groups to which they were originally randomised. However, if data were missing, we used the numbers as reported by the trialists. We contacted trialists for missing data or additional information. </p> <p>If there had been evidence of differential dropout between the groups we would have considered imputing data for the missing results. </p> </section> <section id="CD004013-sec-0041"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed evidence of heterogeneity between trials by visual inspection of forest plots, the Chi<sup>2</sup> test for heterogeneity and the I<sup>2</sup> statistic (<a href="./references#CD004013-bbs2-0072" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>; <a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Thresholds for interpretation of the I<sup>2</sup> statistic were defined according to the <i>Cochrane Handbook for Systematic Reviews of Intervention</i>s (<a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We regarded statistical heterogeneity as substantial if either the I<sup>2</sup> was greater than 50%, or there was a low P value (P &lt; 0.10) in the Chi<sup>2</sup> test for heterogeneity (<a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). In those outcomes, a random‐effects model would have been used. </p> </section> <section id="CD004013-sec-0042"> <h4 class="title">Assessment of reporting biases</h4> <p>Owing to the difficulties involved in the detection and correction for publication bias, as well as other reporting biases, we aimed to minimise the potential impact of these biases by ensuring the implementation of a comprehensive search strategy and by being alert to data duplication. </p> </section> <section id="CD004013-sec-0043"> <h4 class="title">Data synthesis</h4> <p>We only combined data from trials if the trials were clinically similar. We did this by meta‐analysis using a fixed‐effect approach. </p> </section> <section id="CD004013-sec-0044"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We subgrouped data according to the following.</p> <p> <ul id="CD004013-list-0013"> <li> <p>Type of catheter used (e.g. different types of antibiotics used to impregnate antimicrobial catheters). </p> </li> <li> <p>Duration of catheter use (less than, compared with longer than one week).</p> </li> <li> <p>Type of participant (diagnosis or condition).</p> </li> <li> <p>Type of measurement unit for rate of bacteriuria (e.g. per 100 catheters used).</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004013-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004013-sec-0045"></div> <section id="CD004013-sec-0046"> <h3 class="title">Description of studies</h3> <section id="CD004013-sec-0047"> <h4 class="title">Results of the search</h4> <p>We screened a total of 892 records produced by the literature search and retrieved the full‐text of 62 potentially eligible articles. After we assessed the articles, we considered 28 reports of 26 studies to be eligible for inclusion in the review; we excluded 31 reports of 28 studies. Additionally three ongoing studies were identified (<a href="./references#CD004013-bbs2-0055" title="NCT00482547 , RuppM , DulinJ . Study of a urethral catheter coated with eluting silver salts. http://clinicaltrials.gov/show/NCT004825472007. ">NCT00482547 2007</a>; <a href="./references#CD004013-bbs2-0056" title="NCT01681511 , KlineSE . A randomized trial for the safety and effectiveness of a novel antimicrobial‐coated Foley catheter attached to an antimicrobial anti‐reflux device for reduction of catheter‐associated urinary tract infection. http://clinicaltrials.gov/show/NCT016815112012. ">NCT01681511 2012</a>; <a href="./references#CD004013-bbs2-0057" title="NCT02198833 , DarouicheR , FisherK . Clinical study to assess the efficacy of a novel micro‐patterned Foley catheter to reduce catheter‐associated urinary tract infection among spinal cord injury patients. http://clinicaltrials.gov/show/NCT021988332014. ">NCT02198833 2014</a>). The flow of literature through the assessment process is shown in the PRISMA diagram (<a href="#CD004013-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD004013-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram." data-id="CD004013-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> </div> </section> <section id="CD004013-sec-0048"> <h4 class="title">Included studies</h4> <p>We included 26 trials involving 12,223 hospitalised adults in 25 parallel group trials (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>) ) and 27,878 adults in one large cluster‐randomised cross‐over trial (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>) comparing two types of indwelling urethral catheters. </p> <p>Of the 26 included trials, three were published in restricted format: one as a letter to the editor (<a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>) and two as abstracts from scientific meetings (<a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>). We were not able to contact any of these trialists, therefore additional information on the trials came from secondary sources (<a href="./references#CD004013-bbs2-0077" title="Niel‐WeiseBS , ArendSM , van denBroekPJ . Is there evidence for recommending silver‐coated urinary catheters in guidelines?. Journal of Hospital Infection2002;52(2):81‐7. ">Niel‐Weise 2002</a>; <a href="./references#CD004013-bbs2-0090" title="SaintS , ElmoreJG , SullivanSD , EmersonSS , KoepsellTD . The efficacy of silver alloy‐coated urinary catheters in preventing urinary tract infection: A meta‐analysis. American Journal of Medicine1998;105:236‐41. [MEDLINE: 99086386] ">Saint 1998</a>). Furthermore, one of the trials was an unpublished report (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>). All other trials were published as full‐text articles. </p> <section id="CD004013-sec-0049"> <h5 class="title">Participants</h5> <section id="CD004013-sec-0050"> <h6 class="title">Conditions/populations</h6> <p>The trials involved heterogeneous population groups.</p> <p> <ul id="CD004013-list-0014"> <li> <p>Fourteen trials included both women and men catheterised for haemodynamic monitoring or postoperative drainage for a variety of diagnoses (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> </li> <li> <p>Four trials included men with urological diagnoses (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> </li> <li> <p>Two other trials involved men only; one involved men postcardiac surgery (<a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>) and the other included men with a variety of medical and surgical diagnoses (<a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>). </p> </li> <li> <p>One trial included men and women undergoing elective orthopaedic surgery (<a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>). </p> </li> <li> <p>One trial included men and women from trauma and surgical wards, and patients with urinary incontinence (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>). </p> </li> <li> <p>One trial included men and women from trauma centres only (<a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). </p> </li> <li> <p>One trial included men and women catheterised for more than 24 hours in five university hospitals (<a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>). </p> </li> <li> <p>Two trials did not describe the characteristics of the population (<a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>). </p> </li> </ul> </p> </section> <section id="CD004013-sec-0051"> <h6 class="title">Gender</h6> <p>The distribution of men and women was not even between groups in six trials (<a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). In one trial, the intervention group (silver oxide catheter) had nearly twice the number of women than the comparison group (<a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>). The Lee trial included fewer women in the treatment group than the control group and more men in the treatment group than the control. One trial only included men after transurethral resection of the prostate or prostate cancer (<a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>). </p> </section> <section id="CD004013-sec-0052"> <h6 class="title">Antiobiotic use</h6> <p>Six trials reported the number of participants on systemic antibiotics (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>). The numbers were similar across the groups in the trials. Five trials reported on those taking systemic antibiotics prior to catheterisation (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>) and one reported on the number given antibiotics for the final 48 hours of catheterisation (<a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>). One trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) reported on the prescription of antibiotics immediately prior to, and during catheterisation, and within six weeks of catheter removal. </p> <p>No trials included different types of populations, and so we were unable to subgroup the analysis by diagnosis. </p> </section> </section> <section id="CD004013-sec-0053"> <h5 class="title">Interventions and comparisons</h5> <p>The majority of trials randomised participants to an antiseptic‐coated catheter or a standard catheter. Four different types of antiseptic catheters were investigated: </p> <p> <ul id="CD004013-list-0015"> <li> <p>silver oxide (<a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>); </p> </li> <li> <p>silver alloy (<a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>); </p> </li> <li> <p>silver alloy hydrogel (<a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>); and </p> </li> <li> <p>noble metal alloy‐coated latex (<a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>). </p> </li> </ul> </p> <p>Two different types of antimicrobial‐impregnated catheters were studied:</p> <p> <ul id="CD004013-list-0016"> <li> <p>rifampicin/minocycline combination (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>); and </p> </li> <li> <p>nitrofurazone (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). </p> </li> </ul> </p> <p>The types of standard catheters used were heterogeneous:</p> <p> <ul id="CD004013-list-0017"> <li> <p>hydrogel‐coated latex Foley catheter (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>); </p> </li> <li> <p>silicone‐coated latex Foley catheter (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>); </p> </li> <li> <p>fully‐siliconised Foley catheter (<a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>); </p> </li> <li> <p>hydrophilic polymer (Hydron)‐coated latex Foley catheter (<a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>); </p> </li> <li> <p>polyvinyl chloride (PVC) Foley catheter (<a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>); </p> </li> <li> <p>polyvinyl chloride (PVC) three‐way catheter (<a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>); </p> </li> <li> <p>latex Foley catheter (<a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>); </p> </li> <li> <p>latex three‐way catheter (<a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>); </p> </li> <li> <p>polytetrafluoroethylene (PTFE)‐coated latex Foley catheter (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>); and </p> </li> <li> <p>unspecified standard Foley catheter (<a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>). </p> </li> </ul> </p> <p>Two trials randomised participants into three arms: <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a> compared silver alloy, standard (hydrogel‐coated) and standard (non‐coated unspecified) catheters, whilst <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> compared silver alloy hydrogel, nitrofurazone and standard PTFE‐coated latex catheters. Six trials randomised participants to two different types of standard catheters (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> <p>Types of catheters used are summarised in <a href="#CD004013-tbl-0005">Table 1</a>. </p> <div class="table" id="CD004013-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Types of catheters</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Antiseptic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Antibiotic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Standard</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silver oxide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silicone impregnated with minocycline and rifampin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silicone</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silicone impregnated with nitrofurazone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Noble metal alloy containing a mixture of gold, palladium and silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hydrogel</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Siliconised latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Teflonised latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hydrogel‐coated latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hydrophilic polymer‐coated latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polyvinyl chloride</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polytetrafluoroethylene</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD004013-sec-0054"> <h5 class="title">Duration of catheterisation</h5> <p>Short‐term is defined as a duration of catheterisation which is intended to be less than 14 days. There was variation in the duration of catheterisation in the trials. The trials described the length of catheterisation in the following ways: total catheterisation time, total mean length of catheterisation for all participants, and mean or median length of catheterisation in the intervention and control groups. </p> <p> <ul id="CD004013-list-0018"> <li> <p>In one trial the participants were catheterised for forty‐eight hours (<a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>). </p> </li> <li> <p>Another four trials had a total length of catheterisation of five to six days (<a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>;<a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>), </p> </li> <li> <p>Two further trials had a total catheterisation time of fourteen days (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>). </p> </li> <li> <p>Five trials recorded the length of catheterisation as total mean duration catheterised for all participants.The mean time catheterised varied from 44.9 hours in one trial (<a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>) and 2.2 days (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>), three days (<a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>) and five days (<a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> </li> <li> <p>Eight trials described the length of catheterisation as a separate mean for intervention and control groups. One trial reported a mean length of catheterisation of three days in the intervention group and two days in the control group (<a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). Another trial reported a mean length of catheterisation of 3.5 days in the intervention group and 3.4 days in the control group (<a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>). The mean length of catheterisation in both groups in four of the trials ranged from 3.4 to 4.6 days (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>), while one trial had a mean length of catheterisation in the intervention group of 7.7 days and 7.5 in the control group (<a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>), and another of 7.9 in the intervention group and 7.2 in the control group (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>). </p> </li> <li> <p>Another trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) only recruited patients catheterised for up to 14 days, and reported the median duration of catheterisation for each of the three arms, which was balanced across all arms (two days); more than 96% of patients in each arm were catheterised for less than 14 days (balanced across all arms). </p> </li> <li> <p><a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a> recruited patients who were catheterised during elective orthopaedic surgery, and reported the median duration of catheterisation for the two arms, which was balanced across both arms (two days). </p> </li> </ul> </p> <p>Four trials did not clearly specify the length of catheterisation (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>). </p> </section> <section id="CD004013-sec-0055"> <h5 class="title">Outcome measures</h5> <section id="CD004013-sec-0056"> <h6 class="title">Primary outcome</h6> <p>The primary outcome measure, i.e. 'symptomatic CAUTI' was either not assessed or poorly defined in the great majority of studies. Very few studies defined symptomatic CAUTI based on standardised definitions. <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> defined symptomatic CAUTI based on the development of UTI symptoms and signs, and prescription of antibiotics for a presumed UTI, at any time point during catheterisation, or up to six weeks postcatheter removal. This is a variation of a previous CDC symptomatic CAUTI definition, although the time point of six weeks was longer than any standard definitions. This primary outcome did not include any microbiological evidence of a UTI. However, the same study also included symptomatic CAUTI with microbiological evidence as a secondary outcome measure. </p> <p>Another trial (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>) defined bacteriuria or symptomatic or non‐symptomatic UTI as ‘≥ 10<sup>5</sup> cfu/mL’, whilst <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a> defined UTI as ‘bacteriuria (&gt; 10<sup>5</sup> cfu/mL) with &gt; 10 leucocytes per mm<sup>3</sup> of urine'. Darouiche and colleagues defined 'symptomatic bacteriuria' as being 'diagnosed by the healthcare provider' (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>). </p> <p>The main outcome measure for most studies was bacteriuria without any consideration of patient symptoms. The exception to this was <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>, which assessed bacteriuria (&gt; 10<sup>5</sup> cfu/mL) and urinary symptoms during and after the catheterisation period. There was significant heterogeneity in terms of the definition of bacteriuria across trials, ranging from 'greater than 10<sup>2</sup> colony forming units per mL' to 'greater than 10<sup>6</sup> colony forming units per mL'. </p> </section> <section id="CD004013-sec-0057"> <h6 class="title">Secondary outcomes</h6> <section id="CD004013-sec-0058"> <p><b>Adverse effects</b></p> <p>In terms of catheter‐related discomfort or symptoms, only five trials investigated this outcome (<a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>). </p> <p> <ul id="CD004013-list-0019"> <li> <p><a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> measured catheter‐related discomfort at four time points: catheter insertion, whilst the catheter remained in situ, during catheter removal, and within six weeks following catheter removal, using a self administered questionnaire completed by patients. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a> defined urethritis as ‘penile discharge and/or penile discomfort’. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a> measured various adverse effects such as pain, burning sensation and difficulty sleeping because of catheter. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a> used measurement via scanning electron microscopic analysis to indicate urethral inflammatory reaction. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a> also measured catheter‐related pain, but did not provide a definition for this outcome. </p> </li> </ul> </p> </section> <section id="CD004013-sec-0059"> <p><b>Timing of outcome measurement</b></p> <p>The timing of outcome measurement of the four trials that investigated outcomes related to comfort or urethritis, or both, differed considerably. The trial conducted by <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a> and colleagues investigated urethritis with assessment at eight weeks and six months postcatheterisation (length of catheterisation two days) by clinical examination and urethral swabs (<a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>). </p> </section> <section id="CD004013-sec-0060"> <p><b>Definition of outcomes</b></p> <p>The method for gathering the data on catheter‐related pain, urethral discharge and allergic reaction was not described in the <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a> report. The <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a> trial investigated inflammatory reaction in the urethra assessed by cytological urethral swabs taken immediately after catheterisation, after removal of the catheter and on the second or third day after removal. <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a> measured urinary symptoms whilst the catheter remained in situ based on a questionnaire, and 7 to 10 days following catheter removal based on a telephone interview. </p> </section> <section id="CD004013-sec-0061"> <p><b>Other outcomes</b></p> <p><a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> also measured other outcomes, including the development of adverse events, serious events (including urinary sepsis and death), health‐related quality of life (based on the EQ‐5D questionnaire), and economic outcomes. </p> <p>An outcome of interest that was included in the trials of standard catheters was catheter‐related infection. In addition, one small Japanese trial of antiseptic‐coated catheters reported data for: catheter‐associated pain, urethral discharge and catheter‐related hypersensitivity or allergy (<a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>). The six trials that randomised participants to two different types of standard catheters (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>;<a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>) investigated outcomes of catheter‐related infection or catheter‐related urethritis and urethral inflammatory reaction. One trial only reported an adverse effect, meatal stricture (<a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>). </p> <p>Apart from variation in the definition of infection, the timing of the outcome measurement and duration of follow‐up was also diverse. Only six trials (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>) monitored catheter care violations. The method of obtaining urine specimens was varied. The majority of trials acquired samples from the catheter sampling port (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>). However, two trials used suprapubic puncture to obtain urine samples from participants (<a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>), and one trial took specimens from the catheter urine bag, which could have resulted in contamination (<a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>). </p> </section> <section id="CD004013-sec-0062"> <p><b>Economic outcomes</b></p> <p>An economic analysis was performed in two trials. <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a> calculated the total catheter‐related costs by summing the cost of infections and the cost of catheters and their components, and cost savings were estimated by subtracting the total catheter‐related cost for silver‐coated catheters from the total cost for uncoated catheters. The analysis included an estimation of both a lower and higher approximation of costs. <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> measured cost‐effectiveness using a decision‐analytical model, which compared three types of catheters in terms of both UK NHS costs, and quality‐adjusted life‐years (QALYs), based on responses to the EQ‐5D questionnaire. </p> </section> </section> </section> </section> <section id="CD004013-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded twenty‐eight reports (<a href="./references#CD004013-bbs2-0027" title="AnderssonH . A double‐blind randomised comparison of the effect and tolerance of varidase versus saline when instilled in the urinary bladder in patients with catheter problems. Journal of International Medical Research1986;14(2):91‐4. ">Andersson 1986</a>; <a href="./references#CD004013-bbs2-0028" title="BachD , HesseA , PrangeCH . Prevention of incrustations and urinary tract infections during transurethral continuous catheterization [German]. Therapiewoche Urologie Nephrologie1990;2(1):25‐32. ">Bach 1990</a>; <a href="./references#CD004013-bbs2-0029" title="BolognaRA , TuLM , PolanskyM , FraimowHD , GordonDA , WhitmoreKE . Hydrogel/silver ion‐coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology1999;54(6):982‐7. ">Bologna 1999</a>; <a href="./references#CD004013-bbs2-0030" title="BrittMR , GaribaldiRA , MillerWA , HerbertsonRM , BurkeJP . Antimicrobial prophylaxis for catheter‐associated bacteriuria. Antimicrobial Agents and Chemotherapy1977;11(2):240‐3. ">Britt 1977</a>; <a href="./references#CD004013-bbs2-0031" title="ClelandV , CoxF , BerggrenH , MacInnisMR . Prevention of bacteriuria in female patients with indwelling catheters. Nursing Research1971;20(4):309‐18. ">Cleland 1971</a>; <a href="./references#CD004013-bbs2-0032" title="DayRA , MooreKN , AlbersMK . A pilot study comparing two methods of intermittent catheterization: limitations and challenges. Urologic Nursing2003;23(2):143‐7, 158. ">Day 2003</a>; <a href="./references#CD004013-bbs2-0033" title="DomurathB , KutzenbergerJ , KurzeI , KnothHS . Clinical evaluation of a newly developed catheter (SpeediCath Compact Male) in men with spinal cord injury: residual urine and user evaluation. Spinal Cord2011;49(7):817‐21. ">Domurath 2011</a>; <a href="./references#CD004013-bbs2-0034" title="EricksonBA , NavaiN , PatilM , ChangA , GonzalezCM . A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery. Journal of Urology2008;179(1):203‐6. ">Erickson 2008</a>; <a href="./references#CD004013-bbs2-0035" title="GhoreishiJ . Indwelling urinary catheters in cesarean delivery. International Journal of Gynecology and Obstetrics2003;83(3):267‐70. ">Ghoreishi 2003</a>; <a href="./references#CD004013-bbs2-0036" title="GrocelaJA , JuraYH . Top‐vented urinary drainage catheters cause fewer epithelial and vascular changes in the bladder mucosa compared to conventional catheters and may reduce susceptibility to urinary tract infections. Current Urology2010;4(3):136‐41. ">Grocela 2010</a>; <a href="./references#CD004013-bbs2-0037" title="HakvoortR , RooversJ . Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology2012;119(1):113‐4. HakvoortR , RooversJ . Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology2012;119(1):115‐6. HakvoortRA , ThijsSD , BouwmeesterFW , BroekmanAM , RuheIM , VernooijMM , et al. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology2011;118(9):1055‐60. ">Hakvoort 2011</a>; <a href="./references#CD004013-bbs2-0038" title="HartAJ , FowlerJW . Incidence of urethral stricture after transurethral resection of prostate. Effects of urinary infection, urethral flora, and catheter material and size. Urology1981;18(6):588‐91. [SR‐INCONT26236] ">Hart 1981</a>; <a href="./references#CD004013-bbs2-0039" title="LeeJ , HernandezJ . Silver/hydrogel‐coated catheters to reduce incidence of nosocomial urinary tract infection. American Journal of Infection Control1996;224(2):117. ">Lee 1996</a>; <a href="./references#CD004013-bbs2-0040" title="LeoneM , GarnierF , AntoniniF , BimarMC , AlbaneseJ , MartinC . Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Medicine2003;29(3):410‐3. LeoneM , GarnierF , AntoniniF , BimarMC , AlbaneseJ , MartinC . Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Medicine2003;29(4):551‐4. ">Leone 2003</a>; <a href="./references#CD004013-bbs2-0041" title="LeoneM , PerrinAS , GranierI , VisintiniP , BlascoV , AntoniniF , et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Medicine2007;33(4):726‐9. ">Leone 2007</a>; <a href="./references#CD004013-bbs2-0042" title="LericheA , CharvierK , BonniaudV , PeyratL , N'GuyenP , SolerJM , et al. Comparative study of the acceptability of the SpeediCath Set and Actreen set catheterization sets in patients performing self‐catheterization [French]. Progres en Urologie2006;16(3):347‐51. ">Leriche 2006</a>; <a href="./references#CD004013-bbs2-0043" title="LitherlandAT , SchiotzHA . Patient‐perceived discomfort with two coated urinary catheters. British Journal of Nursing2007;16(5):284‐7. ">Litherland 2007</a>; <a href="./references#CD004013-bbs2-0044" title="NakadaJ , KawaharaM , OnoderaS , OishiY . Clinical study of silver lubricath Foley catheter. Hinyokika Kiyo1996;42:433‐8. ">Nakada 1996</a>; <a href="./references#CD004013-bbs2-0045" title="NewtonT , StillJM , LawE . A comparison of the effect of early insertion of standard latex and silver‐impregnated latex Foley catheters on urinary tract infections in burn patients. Infection Control and Hospital Epidemiology2002;23(4):217‐8. ">Newton 2002</a>; <a href="./references#CD004013-bbs2-0046" title="PachlerJ , Fromodt‐MollerC . Pre‐lubricated hydrophilic PVC urethral catheters compared to non‐hydrophilic PVC catheters. Neurology and Urodynamics1998;14(4):325. ">Pachler 1998</a>; <a href="./references#CD004013-bbs2-0047" title="RatahiE , LynskeyT . Preoperative urethral catheterisation in patients undergoing total hip and knee arthroplasty. A randomized controlled trial (Abstract). Journal of Bone and Joint Surgery ‐ British Volume2005;87‐B(Suppl 1):21. ">Ratahi 2005</a>; <a href="./references#CD004013-bbs2-0048" title="RiginiN , EvronS , SadanO , SzmukP , EzriT . Intermittent versus continuous bladder catheterization and labor epidural (Abstract). Anesthesiology2006;105:A907. ">Rigini 2006</a>; <a href="./references#CD004013-bbs2-0049" title="SallamiS , MouineY , RhoumaSB , CherifK , DahmaniA , HorchaniA . Clean intermittent catheterization following urethral stricture surgery using a low friction catheter versus conventional plastic catheter: a prospective, randomized trial. UroToday International Journal2011;4:1. ">Sallami 2011</a>; <a href="./references#CD004013-bbs2-0050" title="SchaefferAJ , StoryKO , JohnsonSM . Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter‐associated bacteriuria. Journal of Urology1988;139(1):69‐73. ">Schaeffer 1988</a>; <a href="./references#CD004013-bbs2-0051" title="ShafikA . The electrified catheter: role in sterilizing urine and decreasing bacteriuria. World Journal of Urology1993;11(3):183‐5. ">Shafik 1993</a>; <a href="./references#CD004013-bbs2-0052" title="SunJL , LuYP , HuangB , TuHL , ZhouXY , ChenQM , et al. Effect of a novel analgesic disposable urinary catheter in prevention of restlessness caused by catheter‐related bladder discomfort in general anesthesia patients in recovery period [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2008;88(25):1750‐2. ">Sun 2008</a>; <a href="./references#CD004013-bbs2-0053" title="TeareEL , LewiH , PeacockA , MarshallS , NortonM , RobertsonMB , et al. 'Silverline', a device for the prevention of nosocomial bacteriuria?. Journal of Hospital Infection1992;21(2):154‐6. ">Teare 1992</a>; <a href="./references#CD004013-bbs2-0054" title="WitjesA , MarbergerM , DelPopoloG , JonssonO , KapsH , ChappleCR , et al. Is a PVC‐free catheter as well tolerated as a PVC catheter? A randomised multi‐centre double blind study in experienced users of clean intermittent catheterisation (Abstract number 100). Neurourology and Urodynamics2008;27(7):688‐9. ">Witjes 2008</a>). The reasons for exclusion are listed in the table <a href="./references#CD004013-sec-0143" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD004013-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>Details of the risk of bias assessment of the individual trials are mentioned in the <a href="./references#CD004013-sec-0142" title="">Characteristics of included studies</a> table. The results are graphically illustrated in <a href="#CD004013-fig-0002">Figure 2</a> and <a href="#CD004013-fig-0003">Figure 3</a>. The results are summarised below. </p> <div class="figure" id="CD004013-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004013-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004013-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004013-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD004013-sec-0065"> <h4 class="title">Allocation</h4> <section id="CD004013-sec-0066"> <h5 class="title">Random sequence generation</h5> <p> <ul id="CD004013-list-0020"> <li> <p>We considered randomisation with allocation concealment to be adequate in six trials and judged it to be at low risk of bias (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>). </p> </li> <li> <p>We judged the method of allocation concealment to be unclear in 15 trials (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>). </p> </li> <li> <p>We found the method of allocation concealment to be inadequate in a further five trials and judged these at high risk of bias (<a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> </li> </ul> </p> </section> <section id="CD004013-sec-0067"> <h5 class="title">Concealment of allocation</h5> <p> <ul id="CD004013-list-0021"> <li> <p>We considered allocation to be adequately concealed in two trials and judged these to be at low risk of bias (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). </p> </li> <li> <p>There was insufficient information to permit judgement in 21 trials (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> </li> <li> <p>We judged three trials to be at high risk of bias (<a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> </li> </ul> </p> </section> </section> <section id="CD004013-sec-0068"> <h4 class="title">Blinding</h4> <section id="CD004013-sec-0069"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p> <ul id="CD004013-list-0022"> <li> <p>We considered blinding to be adequate in three of the included trials (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>); it was achieved in one trial by identical packaging (<a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>). </p> </li> <li> <p>We deemed blinding to be unclear in 20 of the included trials (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>) and inadequate in three of the included trials (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>), with two cases being due to differences in catheter appearance (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> </li> </ul> </p> </section> <section id="CD004013-sec-0070"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>We considered blinding of outcome assessment to be adequate in three of the included trials (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>). We deemed blinding of outcome assessors to be unclear in 22 of the included trials (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>) and inadequate in one trial (<a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> </section> </section> <section id="CD004013-sec-0071"> <h4 class="title">Incomplete outcome data</h4> <p>Data was either complete or accounted for, if missing, in 15 of the included trials and judged to be at low risk of bias (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). It was judged to be at unclear risk of bias for the following 11 trials (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>). </p> </section> <section id="CD004013-sec-0072"> <h4 class="title">Selective reporting</h4> <p>We considered three of the included trials to be at low risk of selective reporting (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>) and the remaining 23 trials to be at unclear risk (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> </section> <section id="CD004013-sec-0073"> <h4 class="title">Other potential sources of bias</h4> <p>The risk of other bias having occurred was unclear in 18 of the included trials (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>) and we deemed eight of the included trials to be at high risk (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>; <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> </section> </section> <section id="CD004013-sec-0074"> <h3 class="title" id="CD004013-sec-0074">Effects of interventions</h3> <p>See: <a href="./full#CD004013-tbl-0001"><b>Summary of findings for the main comparison</b> Antispetic‐coated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</a>; <a href="./full#CD004013-tbl-0002"><b>Summary of findings 2</b> Antimicrobial‐impregnated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</a>; <a href="./full#CD004013-tbl-0003"><b>Summary of findings 3</b> Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter for management of short‐term voiding problems in hospitalised adults</a>; <a href="./full#CD004013-tbl-0004"><b>Summary of findings 4</b> One type of standard catheter versus another standard catheter for management of short‐term voiding problems in hospitalised adults</a> </p> <section id="CD004013-sec-0075"> <h4 class="title">1. Antiseptic‐coated indwelling urethral catheters versus standard indwelling urethral catheters </h4> <p>There were three types of antiseptic catheters compared with a standard catheter: silver oxide, silver alloy, and noble metal alloy. The trials for each were analysed in three subgroups depending on the type of intervention catheter. </p> <section id="CD004013-sec-0076"> <h5 class="title">Silver oxide versus standard catheter</h5> <p>Three trials compared silver oxide‐coated catheters with a standard catheter (<a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a>; <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>; <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>) enrolling a total of 1828 patients. The trials used different standard catheters as the comparison catheter. <a href="./references#CD004013-bbs2-0005" title="JohnsonJR , RobertsPL , OlsenRJ , MoyerKA , StammWE . Prevention of catheter‐associated urinary tract infection with a silver oxide‐coated urinary catheter: clinical and microbiologic correlates. Journal of Infectious Diseases1990;162:1145‐50. ">Johnson 1990</a> used an all‐silicone catheter as the standard catheter, while <a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a> used silicone‐coated latex as the comparison catheter. <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a> did not define the standard catheter used in the trial. Eighty per cent of participants in one of the trials received systemic antibiotics (the reasons were not stated in the trial) (<a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>). All trials included men and women admitted to surgical or medical wards, or both, although Riley had more women in the treatment group (451/745) than in the control group (285/564). In the <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a> trial all the participants had bacteriuria when the trial ended at nine days catheterisation. </p> <section id="CD004013-sec-0077"> <h6 class="title">Symptomatic CAUTI</h6> <p>None of the studies assessed the primary outcome CAUTI as an outcome. Instead, all studies measured bacteriuria as the primary effectiveness outcome. </p> </section> <section id="CD004013-sec-0078"> <h6 class="title">Bacteriuria and other secondary outcomes</h6> <p>Pooling the results of all three trials using a fixed‐effect model did not provide enough evidence to show whether or not there was a reduction in risk of developing bacteriuria (RR 0.90, 95% CI 0.72 to 1.13, <a href="./references#CD004013-fig-0006" title="">Analysis 1.3</a>.1; all three trials measured this outcome at less than one week <a href="./references#CD004013-fig-0007" title="">Analysis 1.4</a>.1). There was no statistically significant difference in the number with bacteriuria between groups. </p> </section> <section id="CD004013-sec-0079"> <h6 class="title">Subgroup analysis</h6> <p>Subgroup analysis was possible in one trial (<a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>). For bacteriuria reported separately in women and men, there was a reduction of risk of almost one‐third with the silver oxide catheter for women (RR 0.63, 95% CI 0.45 to 0.89, <a href="./references#CD004013-fig-0015" title="">Analysis 1.12</a>.2), while for men there was not enough evidence to suggest whether or not there was a difference in risk with the standard catheter (RR 1.62, 95% CI 0.91 to 2.88, <a href="./references#CD004013-fig-0015" title="">Analysis 1.12</a>.3). </p> <p>The trial reported separately on those participants commenced on antibiotics prior to catheterisation but did not state the reason for the antibiotics. Further subgroup analysis of all participants receiving systemic antibiotics indicated that combining antibiotics with silver oxide catheters may reduce the risk of bacteriuria (RR 0.67, 95% CI 0.45 to 0.99, <a href="./references#CD004013-fig-0015" title="">Analysis 1.12</a>.4). Further analysis of women and men separately who received systemic antibiotics suggested that women were protected from bacteriuria with silver oxide catheters (RR 0.50, 95% CI 0.31 to 0.79, <a href="./references#CD004013-fig-0015" title="">Analysis 1.12</a>.5), but there was not enough evidence either way for men (RR 1.02, 95% CI 0.49 to 2.13, <a href="./references#CD004013-fig-0015" title="">Analysis 1.12</a>.6). </p> </section> </section> <section id="CD004013-sec-0080"> <h5 class="title">Silver alloy versus standard catheter</h5> <p>Ten trials compared silver alloy catheter with a standard catheter (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> <p>Most trials included both men and women except for one which included only men after radical prostatectomy (<a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>), and two trials did not state information about the participants (<a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>). </p> <p> <ul id="CD004013-list-0023"> <li> <p><a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> was a three‐armed trial, comparing both silver alloy hydrogel‐coated latex catheter and nitrofurazone‐impregnated silicone catheter with a standard PTFE‐coated latex catheter (control), in hospitalised patients catheterised for 14 days or less. In the trial, 95% of patients were catheterised for perioperative monitoring purposes. The distribution of symptomatic CAUTI baseline risk factors was balanced across the study groups. 73% of patients received prophylactic antibiotics to cover the surgical procedure. The median duration of catheterisation was two days (interquartile range, one to three days). </p> </li> <li> <p><a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a> was a three‐armed trial comparing silver alloy catheters with two non‐antiseptic impregnated catheters; one defined in the trial only as a standard catheter and the other a hydrogel catheter (the results for both these standard catheter groups were combined in the meta‐analyses). </p> </li> <li> <p><a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a> also defined the usual care catheter as 'control' and did not provide any further details. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a> compared the silver alloy catheter with a standard catheter defined as Teflonised latex Foley. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a> used a silver alloy hydrogel catheter versus a latex catheter as the comparison standard catheter. </p> </li> <li> <p>Two trials compared silver alloy versus a standard silicone catheter (<a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>). </p> </li> <li> <p>One trial compared the silver alloy hydrogel catheter versus a standard hydrogel‐coated catheter (<a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>). </p> </li> </ul> </p> <p>Lundeberg did not define the standard catheter used as a comparison with the silver alloy catheters. Three trials monitored catheter care violations (<a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). </p> <p><a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a> compared silver alloy hydrogel‐coated latex catheter with a hydrogel‐coated latex standard catheter in a cluster randomised trial where hospital ward was the unit of randomisation. Data were not presented in a form suitable for meta‐analysis, therefore are reported in Other Data tables only <a href="./references#CD004013-fig-0009" title="">Analysis 1.6</a>. </p> <section id="CD004013-sec-0081"> <h6 class="title">Symptomatic CAUTI</h6> <p>In terms of the primary review outcome, <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> was the only trial which measured symptomatic CAUTI. The trial found no evidence that silver alloy‐coated catheters reduced symptomatic CAUTI risk, using either definitions (non‐microbiological‐based definition: 263/2097, 12.5% versus 271/2144, 12.6%; RR 0.99, 95% CI 0.85 to 1.16, <a href="./references#CD004013-fig-0004" title="">Analysis 1.1</a>.1; microbiological based definition: RR 1.08, 95% CI 0.83 to 1.42, <a href="./references#CD004013-fig-0005" title="">Analysis 1.2</a>.1). </p> </section> <section id="CD004013-sec-0082"> <h6 class="title">Bacteriuria and other secondary outcomes</h6> <p>For bacteriuria, nine trials measured the outcome (<a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). Eight trials defined ‘bacteriuria’ as ‘greater than 10<sup>5</sup> CFU/mL’, whilst <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> defined it as ‘greater than 10<sup>4</sup> CFU/mL’. The timing of the outcome measurement varied considerably between trials. For the analysis, the outcome of bacteriuria was separated into two groups based on the time point of measurement: less than one week of catheterisation, and more than one week of catheterisation. Seven trials reported bacteriuria at less than one week (<a href="./references#CD004013-bbs2-0009" title="LiedbergT , LundebergPE . Refinements in the coating of urethral catheters reduces the incidence of catheter‐associated bacteriuria. European Urology1990;17(3):236‐40. ">Liedberg 1990a</a>; <a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0012" title="LundebergT . Prevention of catheter‐associated urinary tract infections by use of silver impregnated catheters. Lancet1986;2(8514):1031. ">Lundeberg 1986</a>; <a href="./references#CD004013-bbs2-0014" title="MakiDG , KnasinskiV , HalvorsonK , TambyahPA . A novel silver‐hydrogel‐impregnated indwelling urinary catheter reduces CAUTIs: A prospective double‐blind trial. Infection Control and Hospital Epidemiology1998;1992(19):682. ">Maki 1998</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). All the trials used a latex catheter as the control catheter except <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a> which used a silicone control catheter. </p> <p>The results of the meta‐analysis on bacteriuria showed a slight reduction in bacteriuria achieved by silver alloy catheters (RR 0.82, 95% CI 0.73 to 0.92, <a href="./references#CD004013-fig-0006" title="">Analysis 1.3</a>.2). </p> <p>For the seven trials which reported bacteriuria at less than one week, the slight reduction in bacteriuria achieved by silver alloy catheters was still significant (RR 0.54, 95% CI 0.43 to 0.67, <a href="./references#CD004013-fig-0007" title="">Analysis 1.4</a>.2). </p> <p>For the outcome of bacteriuria after more than one week of catheterisation, four trials reported on this outcome (<a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>; <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>). <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a> and <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a> used a latex catheter as the control, whilst <a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a> and <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a> used a silicone control catheter. The pooled results showed a reduction in bacteriuria achieved by silver alloy catheters over standard catheters (RR 0.64, 95% CI 0.51 to 0.80, <a href="./references#CD004013-fig-0008" title="">Analysis 1.5</a>). Subgroup analysis showed that the reduction achieved by silver alloy was greater when latex was used as the control (RR 0.60, 95% CI 0.47 to 0.76, <a href="./references#CD004013-fig-0008" title="">Analysis 1.5</a>.1) compared with silicone as the control (RR 0.88, 95% CI 0.50 to 1.55, <a href="./references#CD004013-fig-0008" title="">Analysis 1.5</a>.2). </p> <p>The results of a cluster‐randomised cross‐over trial comparing silver alloy with standard (silicone) catheters (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>) were not included in the meta‐analyses because data were not available prior to crossover (<a href="./references#CD004013-fig-0009" title="">Analysis 1.6</a>), and also because of the heterogeneity of the outcome definition, which included patients with ‘bacteriuria or symptomatic or non‐symptomatic UTI’ (collectively defined as ‘≥ 10<sup>5</sup> cfu/m’). The results of the rate of bacteriuria per 1000 patient days were 2.66 versus 3.35 (RR 0.79, 95% CI 0.63 to 0.99), the rate of bacteriuria per 100 patients was 1.10 versus 1.36 (RR 0.81, 95% CI 0.65 to 1.01) and the rate of bacteriuria per 100 catheters was 2.13 versus 3.12 (RR 0.68, 95% CI 0.54 to 0.86) (<a href="./references#CD004013-fig-0009" title="">Analysis 1.6</a>). </p> <p>The data from the cluster‐randomised cross‐over trial (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>) suggested that the sliver alloy catheter was better on two out of three outcome measures (<a href="./references#CD004013-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD004013-sec-0083"> <h6 class="title">Adverse effects</h6> <p>One trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) of silver alloy versus standard catheters reported on patient‐reported discomfort as a tertiary outcome. The results suggested that for the period whilst the catheter was in‐situ, silver alloy‐coated catheters were associated with less discomfort than standard catheters (RR 0.84, 95% CI 0.74 to 0.96) (<a href="./references#CD004013-fig-0010" title="">Analysis 1.7</a>.1). Although more people reported pain on removal of antiseptic catheters, this did not reach statistical significance (RR 1.08, 95% CI 0.97 to 1.20, <a href="./references#CD004013-fig-0011" title="">Analysis 1.8</a>). </p> <p>One trial of antiseptic catheters (silver oxide) versus standard catheters included secondary outcomes related to patient comfort and adverse effects of the catheters (<a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a>). They recorded outcome measurements for pain and urethral secretions. No statistically significant difference was found in either outcome but the CIs were wide: </p> <p> <ul id="CD004013-list-0024"> <li> <p>reported urethral secretions (RR 0.72, 95% CI 0.25 to 2.03, <a href="./references#CD004013-fig-0012" title="">Analysis 1.9</a>.1); </p> </li> <li> <p>patients reporting pain with catheters in place (RR 2.35, 95% CI 0.74 to 7.43, <a href="./references#CD004013-fig-0013" title="">Analysis 1.10</a>.1). </p> </li> </ul> </p> </section> <section id="CD004013-sec-0084"> <h6 class="title">Economic outcomes</h6> <p>Two trials reported on economic outcomes (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>). <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> undertook formal cost‐benefit analysis using a decision‐analytical model, comparing silver alloy‐coated catheters with standard PTFE‐coated catheters. The primary economic outcome was incremental cost per quality‐adjusted life‐year (QALY). Healthcare costs were estimated from UK National Health Service (NHS) sources with QALYs calculated from participant completion of the European Quality of Life‐5 Dimensions questionnaire (EQ‐5D). The analysis suggested that silver alloy catheters were unlikely to be cost‐effective for use within UK NHS hospitals at all incremental cost‐effectiveness ratio (ICER) threshold values of between GBP 0 to GBP 50,000. <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a> reported that for the duration of the trial (one year) silver alloy hydrogel catheter usage resulted in a total estimated catheter‐related cost reduction of between 3.3% and 35.5%. This translated to savings of between USD 14,456 and USD 573,293. </p> </section> </section> <section id="CD004013-sec-0085"> <h5 class="title">Noble metal alloy versus standard catheter</h5> <p>One trial (<a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>) compared a noble metal alloy‐coated (containing a mixture of gold, palladium and silver alloy) latex catheter versus standard silicone catheters in patients undergoing elective orthopaedic surgery (n = 439 patients). The outcomes measured were bacteriuria and urinary symptoms. The distribution of symptomatic CAUTI risk factors was balanced across both groups. Ninety‐three per cent of patients received prophylactic antibiotics to cover the surgical procedure. The median duration of catheterisation was two days (range 0 to 16 days). </p> <p>The trialist did not report the primary outcome, symptomatic CAUTI. The trial found a significant reduction in bacteriuria achieved by the metal alloy‐coated latex catheter compared with control (RR 0.25, 95% CI 0.07 to 0.86, <a href="./references#CD004013-fig-0006" title="">Analysis 1.3</a>.3). There were no significant differences in urinary symptoms, either during the period while the catheter remained in situ or within 7 to 10 days following catheter removal between the two groups (RR 0.96, 95% CI 0.67 to 1.38, <a href="./references#CD004013-fig-0014" title="">Analysis 1.11</a>.1). None of the patients who developed bacteriuria complained of any adverse urinary symptoms. </p> </section> </section> <section id="CD004013-sec-0086"> <h4 class="title">2. Antimicrobial‐impregnated indwelling urethral catheters versus standard indwelling urethral catheters </h4> <p>Two types of antimicrobial‐impregnated catheters were compared with a standard catheter: i) minocycline and rifampicin combined; or ii) nitrofurazone. The trials for each were analysed in two subgroups, depending on the type of intervention catheter, and grouped into separate outcomes, dependent upon duration of catheterisation, if this was reported. </p> <section id="CD004013-sec-0087"> <h5 class="title">Nitrofurazone versus standard</h5> <p>Five trials compared nitrofurazone‐impregnated catheters with standard catheters (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>; <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). Three types of standard catheter were used. </p> <p> <ul id="CD004013-list-0025"> <li> <p><a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a> used a latex catheter as the standard catheter whilst <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a> and <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a> both used silicone catheters as the comparison. </p> </li> <li> <p><a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> used a PTFE‐coated latex catheter as the control. </p> </li> <li> <p>One study did not report which catheter they used as a comparator (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>). </p> </li> </ul> </p> <p>All of the patients in one trial received prophylactic antibiotics pre‐ and postoperatively (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>), three trials recorded antibiotic use (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>), whilst two others did not record antibiotic use (<a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0011" title="LiedbergH , LundebergT . Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver‐coated catheters or Bard hydrogel‐coated catheters (Abstract number 769). Journal of Urology1993;149:405A. [21457] ">Liedberg 1993</a>). </p> <p>Only three of the trials adequately described the trial participants, and included both men and women (<a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). However, <a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a> included fewer women in the treatment group compared to the control (23 versus 40) and more men in the treatment group than the control (69 versus 45); the reasons for this were not stated in the trial. In <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>, the ratio of women to men (62%) was balanced across all arms. </p> <section id="CD004013-sec-0088"> <h6 class="title">Symptomatic CAUTI</h6> <p>In terms of the primary review outcome, <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> was the only study which measured symptomatic CAUTI. The median duration of catheterisation was two days (interquartile range, one to three days). For the outcome of symptomatic CAUTI using a non‐microbiological‐based definition, people using nitrofurazone catheters had a slight but statistically significant lower chance of having a UTI compared with standard catheters (228/2153, 10.6% versus 271/2144, 12.6%; RR 0.84, 95% CI 0.71 to 0.99; <a href="./references#CD004013-fig-0016" title="">Analysis 2.1</a>.1). For the outcome of symptomatic CAUTI using a microbiological‐based definition, nitrofurazone catheters achieved a slightly higher reduction against standard catheters (RR 0.69, 95% CI 0.51 to 0.94; <a href="./references#CD004013-fig-0017" title="">Analysis 2.2</a>.1). </p> </section> <section id="CD004013-sec-0089"> <h6 class="title">Bacteriuria and other outcomes</h6> <p>For the outcome of bacteriuria, all five trials reported it as an outcome. All but one trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) defined bacteriuria as ‘≥ 10<sup>3</sup> cfu/mL’; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> defined it as ‘≥ 10<sup>4</sup> cfu/mL’. <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a> also included funguria as an outcome. </p> <p>The trials differed in their timing of the outcome measurement. Three trials investigated the outcomes at less than one week (<a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>; <a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>). <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> did not report bacteriuria at different time periods, but since the majority of patients were catheterised for less than one week (median duration of catheterisation two days, interquartile range one to three days), the outcome for bacteriuria for the study was grouped under ‘less than one week’. Results were pooled using a fixed‐effect model and indicated that at less than one week of catheterisation, the risk of bacteriuria was statistically significantly reduced in the nitrofurazone impregnated catheter group (RR 0.73, 95% CI 0.64 to 0.85, <a href="./references#CD004013-fig-0018" title="">Analysis 2.3</a>.1). </p> <p>For the outcome of bacteriuria at more than one week, only one study measured this outcome (<a href="./references#CD004013-bbs2-0001" title="Al HabdanI , Sadat‐AliM , CoreaJR , Al OthmanA , KamalBA , ShriyanDS . Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. International Surgery2003;88(3):152‐4. [17332] ">Al Habdan 2003</a>). The benefit from nitrofurazone impregnated catheters in preventing bacteriuria at more than one week was inconclusive, due to the small number of patients and relatively few events resulting in wide CIs (RR 0.08, 95% CI 0.00 to 1.33, <a href="./references#CD004013-fig-0019" title="">Analysis 2.4</a>.1) </p> </section> <section id="CD004013-sec-0090"> <h6 class="title">Adverse effects</h6> <p>For adverse effects, one trial compared nitrofurazone catheters versus standard catheters in terms of patient‐reported discomfort as a tertiary outcome (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>). The results suggested that for the period whilst the catheter was in place, and on removal, nitrofurazone catheters were associated with more discomfort, with more patients complaining of discomfort compared with standard catheters (RR 1.26, 95% CI 1.12 to 1.41 (<a href="./references#CD004013-fig-0020" title="">Analysis 2.5</a>.1); and RR 1.43, 95% CI 1.30 to 1.57 (<a href="./references#CD004013-fig-0021" title="">Analysis 2.6</a>.1) respectively). </p> </section> <section id="CD004013-sec-0091"> <h6 class="title">Economic outcomes</h6> <p>One trial reported on economic outcomes comparing nitrofurazone catheters with standard PTFE‐coated catheters (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>). A formal cost‐benefit analysis using a decision‐analytical model was undertaken. The primary economic outcome was incremental cost per quality‐adjusted life‐year (QALY). Healthcare costs were estimated from UK NHS sources with QALYs calculated from participant completion of the European Quality of Life‐5 Dimensions questionnaire (EQ‐5D). The analysis suggested that nitrofurazone catheters could potentially be cost‐saving, with an 84% probability that the incremental cost per QALY would be under GBP 30,000 (i.e. the willingness‐to‐pay threshold typically used in the UK). </p> </section> </section> <section id="CD004013-sec-0092"> <h5 class="title">Minocycline and rifampicin versus standard catheters</h5> <p>Only one small trial (n = 124) compared a minocycline and rifampicin‐impregnated catheter with a standard catheter (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>). This trial included men after radical prostatectomy for prostate cancer and compared a silicone catheter impregnated with minocycline and rifampicin with a standard (silicone) catheter (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>). Outcome measures included bacteriuria (greater than 10<sup>4</sup> colony forming units per mL) at days three, seven and 14, and symptomatic UTI (timing not stated) as defined by the healthcare provider (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>). </p> <p>One of 56 men in the antimicrobial‐impregnated catheter group had symptomatic UTI compared with six of 68 men in the control group (RR 0.20, 95% CI 0.03 to 1.63, <a href="./references#CD004013-fig-0016" title="">Analysis 2.1</a>.2). For bacteriuria, at less than one week, the risk was about two‐thirds lower in the antimicrobial‐impregnated catheter group (RR 0.36, 95% CI 0.18 to 0.73, <a href="./references#CD004013-fig-0018" title="">Analysis 2.3</a>.2); however, at greater than one week the evidence was inconclusive (RR 0.94, 95% CI 0.86 to 1.03, <a href="./references#CD004013-fig-0019" title="">Analysis 2.4</a>.2). </p> </section> </section> <section id="CD004013-sec-0093"> <h4 class="title">3. Antimicrobial‐impregnated indwelling urethral catheters versus antiseptic‐coated indwelling urethral catheters </h4> <p>Only one trial addressed this comparison. <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> was a three‐armed trial, comparing both silver alloy hydrogel‐coated latex catheter and nitrofurazone‐impregnated silicone catheter with a standard PTFE‐coated latex catheter (control), in hospitalised patients catheterised for 14 days or less. Although the study did not directly report on the comparison of antimicrobial (i.e. nitrofurazone) versus antiseptic (i.e. silver alloy) catheters, data from the trial were available to perform this direct comparison. </p> <section id="CD004013-sec-0094"> <h5 class="title">Symptomatic CAUTI</h5> <p>For the primary review outcome of symptomatic CAUTI, using a non‐microbiological‐based definition, people were less likely to have a UTI with nitrofurazone catheters (228/2153, 10.6%) compared with silver alloy (263/2097, 12.5%), but this was of borderline statistical significance (RR 0.84, 95% CI 0.71 to 1.00; <a href="./references#CD004013-fig-0022" title="">Analysis 3.1</a>.1). For the outcome of symptomatic CAUTI using a microbiological‐based definition, this difference was statistically significant in favour of nitrofurazone catheters versus silver alloy catheters (RR 0.64, 95% CI 0.48 to 0.86; <a href="./references#CD004013-fig-0023" title="">Analysis 3.2</a>.1). </p> </section> <section id="CD004013-sec-0095"> <h5 class="title">Bacteriuria and other outcomes</h5> <p>For the outcome of bacteriuria, data from <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> showed that people also had significantly less bacteriuria with nitrofurazone catheters compared with silver alloy catheters (RR 0.78, 95% CI 0.67 to 0.91, <a href="./references#CD004013-fig-0024" title="">Analysis 3.3</a>.1). </p> </section> <section id="CD004013-sec-0096"> <h5 class="title">Adverse effects</h5> <p>For adverse effects, one trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) measured the incidence of any discomfort reported by patients, for patients catheterised with nitrofurazone catheters and silver alloy catheters. </p> <p>For the period whilst the catheter was in‐situ, and on removal, nitrofurazone catheters were associated with more discomfort, with more patients complaining of discomfort while the catheter was in place (RR 1.50, 95% CI 1.32 to 1.70, <a href="./references#CD004013-fig-0025" title="">Analysis 3.4</a>.1); and on removal RR 1.32, 95% CI 1.20 to 1.45, <a href="./references#CD004013-fig-0026" title="">Analysis 3.5</a>.1) compared with silver alloy catheters. </p> </section> <section id="CD004013-sec-0097"> <h5 class="title">Economic outcomes</h5> <p>One trial reported on economic outcomes indirectly comparing nitrofurazone catheters with silver alloy catheters, with both types of catheters being compared directly with standard catheters (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>). The methods and results have been described in earlier sections, under the main comparisons of antiseptic‐coated catheters versus standard catheters, and antimicrobial‐impregnated catheters versus standard catheters. </p> </section> </section> <section id="CD004013-sec-0098"> <h4 class="title">4. One type of standard indwelling urethral catheter versus another type of standard indwelling urethral catheter </h4> <p>Seven trials compared one type of standard catheter with another (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>; <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). </p> <p>Three trials using different outcome measurements compared two types of standard catheters to investigate infection (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>; <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>; <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>). The trials were not combined. All three trials compared different types of standard catheters. </p> <p> <ul id="CD004013-list-0026"> <li> <p>The <a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a> trial compared silicone with latex catheters, using the outcome asymptomatic bacteriuria (defined as greater than 10<sup>6</sup> colony forming units per mLL), with the final measurement recorded 96 hours postcatheterisation. </p> </li> <li> <p>The <a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a> trial compared three types of standard catheters: hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling catheters. The outcome of interest was UTI defined as asymptomatic bacteriuria 10<sup>3</sup> per mL colony forming units. The final outcome measurement was recorded at day five to six postcatheterisation. </p> </li> <li> <p>The <a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a> trial compared hydrogel with silicone catheters and the outcome measurement was asymptomatic bacteriuria. </p> </li> </ul> </p> <p>In a further small trial, <a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a> compared a latex three‐way catheter (size 22G) with a PVC three‐way catheter (size 22G). </p> <p>Three further trials compared different types of standard catheters to investigate urethral side effects in men (<a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>; <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a>; <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>). The outcome measurements differed in all three trials. </p> <p> <ul id="CD004013-list-0027"> <li> <p>The <a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a> trial compared silicone with non‐silicone (not defined further) catheters with an outcome measurement of reported burning sensation in the urethra. </p> </li> </ul> <ul id="CD004013-list-0028"> <li> <p>The <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984</a> trial compared silicone with latex catheters and the outcome was urethritis as measured by swabs of urethral discharge. </p> </li> </ul> <ul id="CD004013-list-0029"> <li> <p>The <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a> trial compared three types of standard catheters: hydrogel‐coated latex, siliconised latex and full silicone. The outcome of interest was urethral reaction measured from cytological urethral swab specimens using scanning electron microscopic analysis. </p> </li> </ul> </p> <section id="CD004013-sec-0099"> <h5 class="title">Symptomatic CAUTI</h5> <p>None of the trials reported the primary outcome.</p> </section> <section id="CD004013-sec-0100"> <h5 class="title">Bacteriuria and other outcomes</h5> <p>One trial (<a href="./references#CD004013-bbs2-0016" title="NickelJC , FeeroP , CostertonW , WilsonE . Incidence and importance of bacteriuria in postoperative, short‐term urinary catheterization. Canadian Journal of Surgery1989;32(2):131‐2. ">Nickel 1989</a>) found no evidence of difference in the risk of bacteriuria between two standard catheters, but they had wide CIs (RR 1.07, 95% CI 0.23 to 5.01, <a href="./references#CD004013-fig-0027" title="">Analysis 4.1</a>.1). </p> <p>The evidence from anther small trial (<a href="./references#CD004013-bbs2-0024" title="TiddMJ , GowJG , PenningtonJH , SheltonJ , ScottMR . Comparison of hydrophilic polymer‐coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. British Journal of Urology1976;48(4):285‐91. ">Tidd 1976</a>) was insufficient to detect a difference in the risk of infection between any of the three standard catheters compared, with wide CIs: hydron‐coated latex versus plain latex (RR 0.94, 95% CI 0.66 to 1.34, <a href="./references#CD004013-fig-0027" title="">Analysis 4.1</a>.2); hydron‐coated latex versus PVC balloon (RR 0.87, 95% CI 0.63 to 1.19, <a href="./references#CD004013-fig-0027" title="">Analysis 4.1</a>.3); PVC balloon versus plain latex (RR 1.09, 95% CI 0.81 to 1.45, <a href="./references#CD004013-fig-0027" title="">Analysis 4.1</a>.4). This trial also had methodologically flawed randomisation in some cases. </p> <p>The results in a further trial (<a href="./references#CD004013-bbs2-0002" title="CheneG , BoulardG , GachieJP . A controlled trial of a new material for coating urinary catheters [Essai controle d'un nouveau materiau pour enduire les sondes urnaires]. Agressologie1990;31(8):499‐501. ">Chene 1990</a>) also had insufficient evidence to say whether or not there was a reduced risk of infection between the two standard catheters (RR 0.82, 95% CI 0.46 to 1.47, <a href="./references#CD004013-fig-0027" title="">Analysis 4.1</a>.5). </p> </section> <section id="CD004013-sec-0101"> <h5 class="title">Adverse effects</h5> <p>In one trial, (<a href="./references#CD004013-bbs2-0006" title="KalambhetiK . Siliconized Foley catheters. American Journal of Surgery1965;110(6):935‐6. ">Kalambheti 1965</a>), results using a fixed‐effect model found that the risk of a burning sensation in the urethra was less in the silicone catheter group than the non‐silicone group (RR 0.28, 95% CI 0.13 to 0.60, <a href="./references#CD004013-fig-0029" title="">Analysis 4.3</a>.1). </p> <p>In <a href="./references#CD004013-bbs2-0015" title="NaceyJN , TullochAGS , FergusonAS . Catheter‐induced urethritis: a comparison between latex and silicone catheters in a prospective clinical trial. British Journal of Urology1984;57:325‐8. ">Nacey 1984,</a> there were fewer cases of urethritis with a silicone catheter (1/50 versus 11/50; RR 0.09, 95% CI 0.01 to 0.68, <a href="./references#CD004013-fig-0030" title="">Analysis 4.4</a>.1). </p> <p>In <a href="./references#CD004013-bbs2-0022" title="TaljaM , KorpelaA , JarviK . Comparison of urethral reaction to full silicone hydrogel‐coated and siliconised latex catheters. British Journal of Urology1990;66(6):652‐7. ">Talja 1990</a>, results using a fixed‐effect model in the comparison of hydrogel‐coated latex versus siliconised latex indicated no difference in urethral reaction (MD 0.00, 95% CI ‐3.51 to 3.51, <a href="./references#CD004013-fig-0028" title="">Analysis 4.2</a>.1). Results of the comparison of full silicone versus hydrogel‐coated latex and siliconised latex found that in both comparisons the risk of urethral reaction was less with a full silicone catheter: full silicone versus hydrogel‐coated latex (MD ‐16.00, 95% CI ‐18.84 to ‐13.16, <a href="./references#CD004013-fig-0028" title="">Analysis 4.2</a>.2); and full silicone versus siliconised latex (MD ‐16.00, 95% CI ‐18.96 to ‐13.04, <a href="./references#CD004013-fig-0028" title="">Analysis 4.2</a>.3). </p> <p>In a fourth small trial (<a href="./references#CD004013-bbs2-0004" title="GoodwinMI , ChesterJF . Meatal strictures after transurethral prostatectomy using latex or polyvinyl chloride three‐way catheters. Annals of the Royal College of Surgeons of England1990;72(2):125‐7. ">Goodwin 1990</a>), only one person in each group had meatal stricture (<a href="./references#CD004013-fig-0031" title="">Analysis 4.5</a>.1). </p> </section> <section id="CD004013-sec-0102"> <h5 class="title">Economic outcomes</h5> <p>None of the trials reported economic outcomes.</p> </section> </section> <section id="CD004013-sec-0103"> <h4 class="title">5. <i>One type of antiseptic‐coated indwelling urethral catheter versus another type of antiseptic‐coated indwelling urethral catheter</i> </h4> <p>No trials were found that addressed this comparison.</p> </section> <section id="CD004013-sec-0104"> <h4 class="title">6. One type of antimicrobial‐impregnated indwelling urethral catheter versus another type of antimicrobial‐impregnated indwelling urethral catheter </h4> <p>No trials were found that addressed this comparison.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004013-sec-0105" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004013-sec-0105"></div> <section id="CD004013-sec-0106"> <h3 class="title" id="CD004013-sec-0106">Summary of main results</h3> <p>This systematic review identified 26 eligible trials that addressed four of the six prestated hypotheses. In addition, three ongoing studies were identified (<a href="./references#CD004013-bbs2-0055" title="NCT00482547 , RuppM , DulinJ . Study of a urethral catheter coated with eluting silver salts. http://clinicaltrials.gov/show/NCT004825472007. ">NCT00482547 2007</a>; <a href="./references#CD004013-bbs2-0056" title="NCT01681511 , KlineSE . A randomized trial for the safety and effectiveness of a novel antimicrobial‐coated Foley catheter attached to an antimicrobial anti‐reflux device for reduction of catheter‐associated urinary tract infection. http://clinicaltrials.gov/show/NCT016815112012. ">NCT01681511 2012</a>; <a href="./references#CD004013-bbs2-0057" title="NCT02198833 , DarouicheR , FisherK . Clinical study to assess the efficacy of a novel micro‐patterned Foley catheter to reduce catheter‐associated urinary tract infection among spinal cord injury patients. http://clinicaltrials.gov/show/NCT021988332014. ">NCT02198833 2014</a>). One trial compared an antiseptic catheter with an antibiotic catheter (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>). No trials were identified that compared one type of antiseptic catheter with another type of antiseptic catheter, or one type of antibiotic catheter with another type of antibiotic catheter. Short‐term is defined as a duration of catheterisation which was intended to be less than 14 days. </p> <section id="CD004013-sec-0107"> <h4 class="title">Antiseptic‐coated indwelling urethral catheters versus standard indwelling urethral catheters. </h4> <p>This comparison included twelve trials that randomised a total of 8317 hospitalised adults (4133 catheterised with antiseptic catheters and 4184 with standard catheters) and one cross‐over trial that randomised hospital wards of 27,878 hospitalised adults. There were three types of antiseptic catheters: silver oxide, silver alloy and noble metal alloy (composed of a mixture of gold, palladium and silver alloy). Most of the trials included in the pooled analysis were small, with only three trials stating they used a power calculation (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>; <a href="./references#CD004013-bbs2-0023" title="ThibonP , LeCoutourX , LeroyerR , FabryJ . Randomized multi‐centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital‐acquired urinary tract infection. Journal of Hospital Infection2000;45(2):117‐24. ">Thibon 2000</a>). </p> <p>For silver oxide (antiseptic‐coated) catheters, none of the included three trials measured the prespecified primary outcome i.e. symptomatic CAUTI. The catheters were not found to prevent bacteriuria in short‐term catheterised hospitalised adults in the three trials included in the analysis. Subgroup analysis by gender in one trial did suggest that women are less likely to develop bacteriuria if they use silver oxide catheters, whereas the evidence for men was inconclusive (<a href="./references#CD004013-bbs2-0018" title="RileyDK , ClassenDC , StevensLE , BurkeJP . A large randomized clinical trial of a silver‐impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. American Journal of Medicine1995;98(4):349‐56. ">Riley 1995</a>). The same trial also suggested that systemic antibiotic use also decreased the rate of bacteriuria in the silver oxide group, particularly in women. These subgroup analyses should be interpreted cautiously, particularly when the overall result suggests no difference. However, silver oxide catheters are no longer manufactured and therefore these data are no longer clinically relevant. </p> <p>For silver alloy (antiseptic‐coated) catheters, out of the 10 included studies, only one trial measured the primary outcome (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>), which did not find any statistically significant reduction in symptomatic CAUTI. This finding was based on two different definitions of symptomatic CAUTI. In both instances, the experimental catheters did not demonstrate any benefit. The study was a well designed and robust RCT, specifically designed to determine the effectiveness of silver alloy catheters in comparison with standard catheters as used in UK National Health Service (NHS) hospitals. Although previous studies (including the present review) found a slight but statistically significant reduction in bacteriuria from the pooled analysis of nine studies (RR 0.83, 95% CI 0.75 to 0.92), the <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> trial confirms that such a reduction is neither clinically significant nor meaningful because of the lack of impact on symptomatic UTI. However, the authors of this trial acknowledged that the trial reflected the way short‐term catheters were used in UK NHS hospitals, where the median duration of catheterisation for the entire cohort (n = 7102) was only two days. </p> <p>To address the issue of whether duration of catheterisation had an effect on the outcome, the authors conducted a subgroup analysis, which showed that the risk of infection was not influenced by the duration of catheterisation. This demonstrates the importance of measuring outcomes which are clinically important and meaningful to patients in clinical trials, rather than surrogate outcomes such as bacteriuria. </p> <p>Other limitations in the meta‐analysis of trials for the outcome of bacteriuria included clinical heterogeneity, such as diverse populations, use of antibiotics and differences in the standard catheter chosen as the comparison. Only one trial reported catheter care violations (<a href="./references#CD004013-bbs2-0010" title="LiedbergH , LundebergT . Silver alloy coated catheters reduce catheter‐associated bacteriuria. British Journal of Urology1990;65(4):379‐81. ">Liedberg 1990b</a>). The method of urine specimen collection also differed between the trials, from two trials using the gold standard method of suprapubic puncture (<a href="./references#CD004013-bbs2-0025" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999a</a>; <a href="./references#CD004013-bbs2-0026" title="VerleyenP , DeRidderD , VanPoppelH , BaertL . Clinical application of the Bardex IC Foley catheter. European Urology1999;36(3):240‐6. ">Verleyen 1999b</a>), five using various methods to collect the specimen directly from the catheter and one trial collecting the specimen from the drainage bag, which increases the likelihood of bacterial contamination. </p> <p>For noble metal alloy (antiseptic‐coated) catheters, one study (<a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a>) found a dramatic reduction in bacteriuria in comparison with standard silicone catheters (RR 0.27, 95% CI 0.08 to 0.95). Rather oddly, the primary outcome of the study was bacteriuria rather than symptomatic CAUTI, although there was an opportunity for the trialists to measure symptomatic UTI, considering they assessed for the presence of urinary symptoms. As such, the clinical significance of the findings remains uncertain. </p> <p>Catheterised men and women generally develop bacteriuria in different ways due to their anatomical differences. Men are more likely to develop catheter‐related bacteriuria via the intraluminal route from a contaminated drainage bag, while in women contamination is more often transurethral when bacteria migrate from the periurethral region after faecal contamination. One major limitation of the silver alloy trials was that subgroup analysis was not possible by gender. Subgrouping of the results by duration of catheterisation was possible, however, and this indicated that the effect of silver alloy catheters on bacteriuria persisted beyond one week of catheterisation up to two weeks. </p> <p>In terms of adverse effects or catheter‐related discomfort, only three trials assessed these outcomes on antiseptic catheters compared with standard catheters. <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> found silver alloy catheters were no worse than standard catheters, whilst <a href="./references#CD004013-bbs2-0020" title="StenzeliusK , PerssonS , OlssonUB , StjarnebladM . Noble metal alloy‐coated latex versus silicone Foley catheter in short‐term catheterization: a randomized controlled study. Scandinavian Journal of Urology and Nephrology2011;45(4):258‐64. ">Stenzelius 2011</a> found no differences between noble metal alloy catheters and standard catheters. Although <a href="./references#CD004013-bbs2-0021" title="TakeuchiH , HidaS , YoshidaO , UedaT . Clinical study on efficacy of a Foley catheter coated with silver‐protein in prevention of urinary tract infections. Hinyokika Kiyo1993;39(3):293‐8. ">Takeuchi 1993</a> measured patient comfort and adverse effects related to silver oxide catheters, the trial was underpowered and poorly designed, and the methods for collecting the secondary outcome data were not described; this precluded any meaningful interpretation of the trial findings. </p> <section id="CD004013-sec-0108"> <h5 class="title">Economic evaluation</h5> <p>There have been no trials that investigated the issue of whether patients catheterised with antiseptic catheters may develop antimicrobial resistance. Two trials undertook economic evaluation. <a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a> was a large cluster‐randomised cross‐over trial which also included an economic analysis; the study found data in favour of silver alloy hydrogel catheters (<a href="./references#CD004013-bbs2-0007" title="KarchmerTB , GiannettaET , MutoCA , StrainBA , FarrBM . A randomized crossover study of silver‐coated urinary catheters in hospitalized patients. Archives of Internal Medicine2000;160(2):3294‐8. ">Karchmer 2000</a>). Silver alloy catheters were significantly more expensive than standard catheters. The cost estimates derived in the trial used both a low and high approximation of costs and calculated catheter‐related cost reduction of between 3.3% and 35.5%. The limitation of this trial was firstly, the randomisation of hospital wards rather than individual patients, and secondly, the risk of cross‐over of catheters leading to contamination between groups. (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> undertook formal economic analysis of silver alloy catheters versus standard catheters using an economic model. In the absence of any evidence of clinical effectiveness, the trial concluded that silver alloy catheters were unlikely to be cost‐effective for the UK NHS. </p> <p>Elsewhere, outside this review, the issue of cost‐effectiveness of silver alloy catheters has also been covered by other studies, albeit in an indirect way. Plowman developed an illustrative model of the annual costs and benefits associated with the use of silver alloy catheters in hospitalised medical and surgical inpatients in NHS hospitals in England (<a href="./references#CD004013-bbs2-0084" title="PlowmanR , GravesN , EsquiveJ , RobertsJA . An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients. Journal of Hospital Infection2001;48(1):38‐42. ">Plowman 2001</a>). The model suggested that a reduction in the incidence of UTI of 14.6% in catheterised medical patients and 11.4% in catheterised surgical patients would ensure that the cost of silver alloy catheters was the same as standard catheters. Any further reduction in incidence would then result in cost savings. In another study conducted in the USA, <a href="./references#CD004013-bbs2-0091" title="SaintS , VeenstraDL , SullivanSD , ChenowethC , FendrickAM . The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Archives of Internal Medicine2000;160(17):2670‐5. ">Saint 2000</a> developed a cost‐benefit decision model using a simulated cohort of 1000 hospitalised general medical, surgical, urologic and intensive care patients requiring short‐term catheterisation (two to ten days) comparing silver alloy with standard catheters (<a href="./references#CD004013-bbs2-0091" title="SaintS , VeenstraDL , SullivanSD , ChenowethC , FendrickAM . The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Archives of Internal Medicine2000;160(17):2670‐5. ">Saint 2000</a>). The results were calculated using a relative risk reduction of bacteriuria with the use of silver alloy catheters of 25%. They calculated that the use of silver alloy catheters could lead to a 47% relative decrease in the incidence of symptomatic UTI (from 30 to 16 cases per 1000 patients), with a number needed to treat (NNT) of 74, as well as a relative decrease in resultant bacteraemia of 44% (from 4.5 to 2.5 cases), with a NNT of 500. Using a multivariate sensitivity analysis and Monte Carlo simulation, they indicated that silver alloy catheters could provide benefit in all cases and cost savings in 84% of cases. However, without any clinical benefit in terms of significant reductions in symptomatic CAUTI, it is hard to imagine how these potential economic benefits could have been achieved. </p> </section> </section> <section id="CD004013-sec-0109"> <h4 class="title">Antimicrobial‐impregnated indwelling urethral catheters versus standard indwelling urethral catheters </h4> <p>This comparison included the results of six trials that randomised a total of 5248 hospitalised adults (2625 catheterised with antimicrobial‐impregnated catheters and 2623 with standard catheters). There were two types of antimicrobial‐impregnated catheters: minocycline combined with rifampicin and nitrofurazone alone. </p> <p>As with the antiseptic trials, the antimicrobial trials included in the pooled analysis were of small numbers of participants, with the exception of <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>. Only <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> measured symptomatic CAUTI, whilst the rest measured bacteriuria as the main outcome measure. </p> <p>Of the six studies, only one of these (<a href="./references#CD004013-bbs2-0003" title="DarouicheRO , SmithJA , HannaH , DhabuwalaCB , SteinerMS , BabaianRJ , et al. Efficacy of antimicrobial‐impregnated bladder catheters in reducing catheter‐associated bacteriuria: A prospective, randomised, multicentre clinical trial. Urology1999;54(6):976‐87. ">Darouiche 1999</a>) investigated minocycline‐ and rifampicin‐impregnated catheters compared with a standard catheter. This relatively small trial was not powered to detect differences in bacteriuria. It included a very limited population (men after radical prostatectomy) and therefore the benefit shown in reducing bacteriuria in those catheterised for less than a week may not be applicable to other groups of adult patients, particularly women. In fact, one of the inclusion criterion was sterile urine prior to catheterisation which would be unlikely to be found in more high risk groups. There was not enough evidence to show whether this difference persisted after the first week. Adverse effects, such as antimicrobial resistance to the catheters over time, were not investigated. Moreover, minocycline‐ and rifampicin‐impregnated catheters are no longer in clinical use and therefore these data are no longer clinically relevant. </p> <p>There were five other antimicrobial trials that investigated nitrofurazone‐impregnated catheters against standard controls. Based on only one study (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>), the review found that nitrofurazone catheters achieved a slight but statistically significant reduction in symptomatic CAUTI, depending on the definition of the outcome. For the outcome of bacteriuria, the pooled data from four studies also showed a significant reduction at one week. The data regarding duration of catheterisation beyond one week were inconclusive. </p> <p>Of the four trials that investigated the effect of nitrofurazone‐impregnated catheters against standard catheters on bacteriuria at less than one week, three of these studies were well designed to minimise bias (<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a>; <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>; <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a>);<a href="./references#CD004013-bbs2-0013" title="MakiDG , HolcombRG . A report on the randomized, controlled clinical trial of the nitrofurazone‐impregnated, antibacterial, indwelling urinary catheter [unpublished report]. Stewartville, Minnesota: Rochester Medical Corporation; 1997 Apr. Stewartville, Minnesota: Rochester Medical Corporation. ">Maki 1997</a> and <a href="./references#CD004013-bbs2-0019" title="StensballeJ , TvedeM , LoomsD , LippertFK , DahlB , TonnesenE , et al. Infection risk with nitrofurazone‐impregnated urinary catheters in trauma patients: a randomized trial. Annals of Internal Medicine2007;147(5):285‐93. [SR‐INCONT23739] ">Stensballe 2007</a> were relatively small trials. The other trial (<a href="./references#CD004013-bbs2-0008" title="LeeSJ , KimSW , ChoYH , ShinWS , LeeSE , KimCS , et al. A comparative multicentre study on the incidence of catheter‐associated urinary tract infection between nitrofurazone‐coated and silicone catheters. International Journal of Antimicrobial Agents2004;24(Suppl 1):S65‐9. [20993] ">Lee 2004</a>) demonstrated bias in its selection criteria with an unequal distribution of men and women in the control and treatment groups. </p> <p>In terms of catheter‐related discomfort, <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> was the only study which assessed this outcome for nitrofurazone catheters in comparison with standard catheters. Up to 43% more patients who received the nitrofurazone catheter complained of catheter‐related discomfort for the period whilst the catheter was in situ and on catheter removal, compared with standard catheters. This finding is likely to be clinically relevant to patients, and is probably due to the different properties of the catheter material. </p> <p>Taken together, these data indicate a small but statistically significant benefit regarding clinically relevant outcomes achieved by these catheters, whilst being associated with more discomfort. </p> <section id="CD004013-sec-0110"> <h5 class="title">Economic evaluation</h5> <p>Data regarding economic evaluation of nitrofurazone catheters were obtained from <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>, who undertook formal economic analysis of nitrofurazone catheters versus standard catheters using an economic model. Based on incremental cost per quality‐adjusted life‐year (QALY) calculated from the perspective of the UK NHS using self administered questionnaires, the study concluded that there was a high (84%) probability that the catheters could be cost‐effective within NHS hospitals, although this estimate was associated with some uncertainty. Part of the methodological problems related to the length of hospital stay, which appeared to be unbalanced within the study arms; in the majority of circumstances, duration of hospital stay was not related to the presence of the catheter or to CAUTI, but rather to underlying medical conditions or surgical procedures. </p> </section> </section> <section id="CD004013-sec-0111"> <h4 class="title">Antimicrobial‐impregnated indwelling urethral catheters versus antiseptic‐coated indwelling urethral catheters </h4> <p>Data for this comparison were provided by <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>, which compared nitrofurazone (antimicrobial‐impregnated) catheters and silver alloy (antiseptic‐coated) catheters against standard catheters in a three‐armed trial. The results showed that nitrofurazone catheters were superior to silver alloy catheters in reducing both symptomatic CAUTI and bacteriuria. However, up to 50% more patients who received nitrofurazone catheters complained of catheter‐related discomfort compared with those who received silver catheters. The potential clinical benefit of nitrofurazone catheters must be balanced against the likelihood that it will cause greater discomfort. </p> <section id="CD004013-sec-0112"> <h5 class="title">Economic evaluation</h5> <p><a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> also performed formal economic evaluation of nitrofurazone catheters versus silver alloy catheters. Both catheters were compared with standard catheters, and the results suggested that silver alloy catheters were unlikely to be cost‐effective, whilst nitrofurazone catheters could potentially be cost‐effective for use in UK NHS hospitals. </p> </section> </section> <section id="CD004013-sec-0113"> <h4 class="title">One type of standard indwelling urethral catheter versus another type of standard indwelling urethral catheter </h4> <p>This comparison included six trials that randomised a total of 653 hospitalised adults to different types of standard catheters. Three small trials looked at the likelihood of infection between types of standard catheters. There were significant clinical differences between the trials, in terms of: comparison of different types of standard catheters, inclusion of different types of patients and variable outcome measurements. For these reasons, the data from these trials were not pooled. None of the trials, however, provided sufficient evidence to suggest whether any type of standard catheter was superior than another in terms of reducing the rate of bacteriuria. </p> <p>Another three trials investigated adverse effects of standard catheters, in particular urethral side effects in men. As before, the trials were clinically heterogenous. All the trials included different outcome measures and the catheters compared were diverse. The results indicated that siliconised catheters were less likely to result in adverse urethral effects in men, but each outcome was addressed only in single small trials. </p> </section> </section> <section id="CD004013-sec-0114"> <h3 class="title" id="CD004013-sec-0114">Overall completeness and applicability of evidence</h3> <p>The primary objective of this review was to determine the effectiveness of different types of indwelling urethral catheter in reducing the risk of UTI in adults who undergo short‐term urethral catheterisation in hospitals. Although 26 RCTs were included, only one trial ((<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) measured symptomatic CAUTI using standardised definitions. The trial was designed to assess the catheters as they are used within UK NHS hospitals as short‐term catheters only. The majority of patients (95%) were patients undergoing elective surgery and were catheterised for perioperative monitoring purposes. As such, the study and review findings have to be interpreted accordingly. </p> <p>It remains unknown if the effectiveness results regarding the experimental catheters would apply to longer‐term catheters, although the trial did not find any interaction between catheter duration and reduction of CAUTI risk. Equally, the impact of the catheters on different groups of patients, for instance those at high risk of developing CAUTIs (i.e. patients in Intensive Therapy Units, patients undergoing urological surgery, or patients with recurrent UTIs) remains uncertain. </p> <p>In addition, none of the identified trials addressed the following potentially important question: </p> <p> <ul id="CD004013-list-0030"> <li> <p>Is one type of antimicrobial‐impregnated indwelling urethral catheter better than another type of antimicrobial‐impregnated indwelling urethral catheter? </p> </li> </ul> </p> <p>Consequently, further trials may be required to address the above uncertainties.</p> </section> <section id="CD004013-sec-0115"> <h3 class="title" id="CD004013-sec-0115">Quality of the evidence</h3> <p>We contacted content experts to identify critical outcomes relevant to patients undergoing short‐term urethral catheterisation that could be included in this systematic review. Subsequently, we identified five patients who had undergone urethral catheterisation and invited them to take part in a focus group to identify important outcomes from their perspective. The review authors believe that the current work demonstrates the importance of patient involvement when developing Cochrane reviews and for identifying critical outcomes in order to maximise their relevance (<a href="./references#CD004013-bbs2-0080" title="OmarMI , LamT , MacLennan . Critical outcomes in a Cochrane Systematic Review: patients’ perspective. Cochrane Database Syst Rev Suppl 1‐212. 2013:2. [DOI:10.1002/14651858.CD201300] ">Omar 2013</a>). </p> <p>The assessment of the quality of the evidence was performed using GRADE, based on the four critical outcomes identified by this process: symptomatic CAUTI, patient discomfort whilst catheter is in‐situ, bacterial resistance towards the antimicrobial agent, and urinary sepsis (<a href="./references#CD004013-bbs2-0080" title="OmarMI , LamT , MacLennan . Critical outcomes in a Cochrane Systematic Review: patients’ perspective. Cochrane Database Syst Rev Suppl 1‐212. 2013:2. [DOI:10.1002/14651858.CD201300] ">Omar 2013</a>). </p> <p>There was high quality evidence from one large trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) that silver alloy (antiseptic‐coated) catheters did not significantly reduce symptomatic CAUTI (RR 0.99, 95% CI 0.85 to 1.16). No trial reported CAUTI for silver oxide (antiseptic‐coated) catheters. </p> <p>There was high quality evidence from the same trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) that nitrofurazone‐impregnated (antimicrobial‐impregnated) catheters achieved a slight but statistically significant reduction in symptomatic CAUTI compared with standard catheters (RR 0.84, 95% CI 0.71 to 0.99). No trial reported CAUTI for minocycline/rifampicin (antimicrobial‐impregnated) catheters. </p> <p>The quality of evidence for the other outcomes is summarised in the following tables: <a href="./full#CD004013-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD004013-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD004013-tbl-0003">summary of findings Table 3</a>; Summary of findings table 5; Summary of findings table 6; <a href="./full#CD004013-tbl-0004">summary of findings Table 4</a>. </p> <p>In general the risk of bias from the smaller trials was high due to lack of adequate reporting or use of standardised methods. </p> </section> <section id="CD004013-sec-0116"> <h3 class="title" id="CD004013-sec-0116">Potential biases in the review process</h3> <p>We searched all the important databases and imposed no language restriction in our search strategy. However, we were mindful that these databases might not have contained all the potentially eligible trials. We made every effort to ensure adherence to the methods as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004013-bbs2-0073" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Some of the authors of this review (TL and KG) were directly involved in the Catheter Trial (<a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a>) as co‐applicants. In order to minimise bias, the risk of bias assessment of <a href="./references#CD004013-bbs2-0017" title="PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short‐term catheterisation in hospital: a multicentre randomised controlled trial. Lancet2012; Vol. 380, issue 1927:1935. [DOI: 10.1016/S0140‐6736(12)61380‐4] PickardR , LamT , MacLennanG , StarrK , KilonzoM , McPhersonG , et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short‐term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial‐ and antiseptic‐impregnated urethral catheters (the CATHETER trial). Health Technology Assessment2012;16(47):1‐197. SchummK , N'DowJ , NorrieJ , CATHETER Study Group. Recruitment challenges in a large randomised controlled trial with complex processes (Abstract number P06). Proceedings of the 29th Society for Clinical Trials Annual Meeting; 2008 May 18‐21 May; St Louis. St Louis (MO), 2008. ">Pickard 2012</a> and GRADE quality of evidence assessments were performed by other authors who were not involved with the trial (MO and EF). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004013-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram." data-id="CD004013-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004013-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004013-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 1 Symptomatic CAUTI: using non‐microbiological‐based definition." data-id="CD004013-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 1 Symptomatic CAUTI: using non‐microbiological‐based definition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 2 Symptomatic CAUTI: using microbiological‐based definition." data-id="CD004013-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 2 Symptomatic CAUTI: using microbiological‐based definition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 3 Number with bacteriuria." data-id="CD004013-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 3 Number with bacteriuria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 4 Number with bacteruria (&lt; 1 week)." data-id="CD004013-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 4 Number with bacteruria (&lt; 1 week). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 5 Number with bacteriuria (&gt;1 week)." data-id="CD004013-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 5 Number with bacteriuria (&gt;1 week). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0009"> <p> <div class="table" id="CD004013-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Silver</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk Ratio</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Bacteriuria rate per 1000 patient days</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karchmer 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79, 95% CI 0.63 to 0.99</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Bacteriuria rate per 100 patients</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karchmer 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81, 95% CI 0.65 to 1.01</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Bacteriuria rate per 100 catheters</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karchmer 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68, 95% CI 0.54 to 0.86</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 6 Cross‐over trial. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0009">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004013-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 7 Patient discomfort whilst catheter is in situ." data-id="CD004013-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 7 Patient discomfort whilst catheter is in situ. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 8 Number with pain on catheter removal." data-id="CD004013-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 8 Number with pain on catheter removal. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 9 Number with urethral secretions." data-id="CD004013-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 9 Number with urethral secretions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 10 Number with pain with catheter in place." data-id="CD004013-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 10 Number with pain with catheter in place. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 11 Number with urinary symptoms (7 ‐ 10 days post‐catheterisation)." data-id="CD004013-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 11 Number with urinary symptoms (7 ‐ 10 days post‐catheterisation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 12 Number with bacteriuria ‐ subgroup analysis for silver oxide catheters." data-id="CD004013-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Antiseptic‐coated catheter versus standard catheter, Outcome 12 Number with bacteriuria ‐ subgroup analysis for silver oxide catheters. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 1 Symptomatic CAUTI: using non‐microbiological‐based definition." data-id="CD004013-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 1 Symptomatic CAUTI: using non‐microbiological‐based definition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 2 Symptomatic CAUTI: using microbiological‐based definition." data-id="CD004013-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 2 Symptomatic CAUTI: using microbiological‐based definition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 3 Number with bacteriuria (&lt; 1 week)." data-id="CD004013-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 3 Number with bacteriuria (&lt; 1 week). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 4 Number with bacteriuria (&gt; 1 week)." data-id="CD004013-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 4 Number with bacteriuria (&gt; 1 week). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 5 Number with pain with catheter in place." data-id="CD004013-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 5 Number with pain with catheter in place. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 6 Number with pain on catheter removal." data-id="CD004013-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Antimicrobial‐impregnated catheter versus standard catheter, Outcome 6 Number with pain on catheter removal. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 1 Symptomatic CAUTI: using non‐microbiological‐based definition." data-id="CD004013-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 1 Symptomatic CAUTI: using non‐microbiological‐based definition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 2 Symptomatic CAUTI: using microbiological‐based definition." data-id="CD004013-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 2 Symptomatic CAUTI: using microbiological‐based definition. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 3 Number with bacteriuria." data-id="CD004013-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 3 Number with bacteriuria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 4 Number with pain with catheter in place." data-id="CD004013-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 4 Number with pain with catheter in place. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 5 Number with pain on catheter removal." data-id="CD004013-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Antimicrobial‐coated catheter versus antiseptic‐coated catheter, Outcome 5 Number with pain on catheter removal. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One type of standard catheter versus another standard catheter, Outcome 1 Number with bacteruria." data-id="CD004013-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 One type of standard catheter versus another standard catheter, Outcome 1 Number with bacteruria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One type of standard catheter versus another standard catheter, Outcome 2 Urethral reaction." data-id="CD004013-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 One type of standard catheter versus another standard catheter, Outcome 2 Urethral reaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One type of standard catheter versus another standard catheter, Outcome 3 Number with burning sensation in urethra." data-id="CD004013-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 One type of standard catheter versus another standard catheter, Outcome 3 Number with burning sensation in urethra. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One type of standard catheter versus another standard catheter, Outcome 4 Number with urethritis." data-id="CD004013-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 One type of standard catheter versus another standard catheter, Outcome 4 Number with urethritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004013-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/urn:x-wiley:14651858:media:CD004013:CD004013-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_t/tCD004013-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One type of standard catheter versus another standard catheter, Outcome 5 Number with meatal stricture." data-id="CD004013-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 One type of standard catheter versus another standard catheter, Outcome 5 Number with meatal stricture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/media/CDSR/CD004013/image_n/nCD004013-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004013-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antispetic‐coated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antiseptic‐coated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> antiseptic‐coated catheter versus standard catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antiseptic‐coated catheter versus standard catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ silver alloy versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4241<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ silver alloy versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4241<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary sepsis</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ‐ silver oxide versus standard</b> <br/> Number with pain with catheter in place </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ‐ silver alloy versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3718<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1,2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Only one trial.<br/> <sup>2</sup> Not applicable as there is only one trial.<br/> <sup>3</sup> 95% confidence interval is wide (0.83 to 1.42)<br/> <sup>4</sup> Sequence generation and allocation concealment unclear.<br/> <sup>5</sup> GRADE‐specific outcome was patient reported discomfort whilst trial reported patient reported pain.<br/> <sup>6</sup> 95% confidence interval is very wide (0.48 to 4.27) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antispetic‐coated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004013-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antimicrobial‐impregnated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> antimicrobial‐impregnated catheter versus standard catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antimicrobial‐impregnated catheter versus standard catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ nitrofurazone versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4297<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ nitrofurazone versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4297<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards the antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ ‐ nitrofurazone versus standard</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3768<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Not applicable because there was only one trial. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004013-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> antimicrobial‐impregnated catheter versus antiseptic‐coated catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ antibiotic versus silver alloy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.84</b> <br/> (0.71 to 1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4250<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>125 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b> <br/> (89 to 125) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards the antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ antibiotic versus silver alloy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.64</b> <br/> (0.48 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4250<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>50 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b> <br/> (24 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Patient discomfort whilst catheter is in situ</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.5</b> <br/> (1.32 to 1.7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3708<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>176 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>264 per 1000</b> <br/> (232 to 299) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Not applicable because there was only one trial.<br/> <sup>2</sup> 95% Confidence interval is wide (0.71 to 1.00). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus antiseptic‐coated catheter for management of short‐term voiding problems in hospitalised adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004013-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">One type of standard catheter versus another standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>One type of standard catheter versus another standard catheter for management of short‐term voiding problems in hospitalised adults</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients with an indwelling urethral catheter of short‐term duration<br/> <b>Settings:</b> Hospital<br/> <b>Intervention:</b> one type of standard catheter versus another standard catheter </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> One type of standard catheter versus another standard catheter</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: with microbiological evidence ‐ nitrofurazone versus standard</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bacterial resistance towards the antimicrobial agent</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient discomfort whilst catheter is in situ</b> <br/> Number with burning sensation in urethra ‐ Silicone versus non‐silicone </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptomatic CAUTI: without microbiological evidence ‐ nitrofurazone versus standard</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Did not specify the method of sequence generation and allocation concealment.<br/> <sup>2</sup> Only one trial.<br/> <sup>3</sup> Burning sensation in urethra is used as a proxy of patient discomfort.<br/> <sup>4</sup> Only one trial. Funnel plot not applicable. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">One type of standard catheter versus another standard catheter for management of short‐term voiding problems in hospitalised adults</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004013-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Types of catheters</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Antiseptic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Antibiotic</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Standard</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silver oxide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silicone impregnated with minocycline and rifampin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silicone</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Silicone impregnated with nitrofurazone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Noble metal alloy containing a mixture of gold, palladium and silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hydrogel</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Siliconised latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Teflonised latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hydrogel‐coated latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hydrophilic polymer‐coated latex</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polyvinyl chloride</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polytetrafluoroethylene</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Types of catheters</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/full#CD004013-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004013-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antiseptic‐coated catheter versus standard catheter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic CAUTI: using non‐microbiological‐based definition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Silver alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Symptomatic CAUTI: using microbiological‐based definition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Silver alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number with bacteriuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Silver oxide versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1828</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Silver alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.73, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Noble metal alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.07, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number with bacteruria (&lt; 1 week) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Silver oxide versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1828</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Silver alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.43, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number with bacteriuria (&gt;1 week) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>577</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.51, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Silver alloy versus latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.47, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Silver alloy versus silicone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.50, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cross‐over trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Bacteriuria rate per 1000 patient days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Bacteriuria rate per 100 patients</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Bacteriuria rate per 100 catheters</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Patient discomfort whilst catheter is in situ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Silver alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Number with pain on catheter removal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Silver alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Number with urethral secretions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Silver oxide versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Number with pain with catheter in place <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Silver oxide versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Number with urinary symptoms (7 ‐ 10 days post‐catheterisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Noble metal alloy versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Number with bacteriuria ‐ subgroup analysis for silver oxide catheters <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 All participants: silver oxide versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1828</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 All women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.45, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 All men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>573</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.91, 2.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 All participants receiving systemic antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1049</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.45, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 All women receiving systemic antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.31, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6 All men receiving systemic antibiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.49, 2.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antiseptic‐coated catheter versus standard catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004013-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus standard catheter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic CAUTI: using non‐microbiological‐based definition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Nitrofurazone versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Minocycline and rifampicin versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Symptomatic CAUTI: using microbiological‐based definition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Nitrofurazone versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number with bacteriuria (&lt; 1 week) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nitrofurazone versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.64, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Minocycline and rifampicin versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.18, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number with bacteriuria (&gt; 1 week) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.76, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Nitrofurazone versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Minocycline and rifampicin versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.86, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number with pain with catheter in place <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Nitrofurazone versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number with pain on catheter removal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Nitrofurazone versus standard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antimicrobial‐impregnated catheter versus standard catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004013-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Antimicrobial‐coated catheter versus antiseptic‐coated catheter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptomatic CAUTI: using non‐microbiological‐based definition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Nitrofurazone versus silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Symptomatic CAUTI: using microbiological‐based definition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Nitrofurazone versus silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number with bacteriuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nitrofurazone versus silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number with pain with catheter in place <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Nitrofurazone versus silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number with pain on catheter removal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Nitrofurazone versus silver alloy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Antimicrobial‐coated catheter versus antiseptic‐coated catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004013-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">One type of standard catheter versus another standard catheter</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number with bacteruria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Silicone versus latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Hydron coated latex versus plain latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Hydron coated latex versus PVC balloon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 PVC balloon versus plain latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Hydrogel versus silicone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urethral reaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Siliconised Latex versus Hydrogel coated latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Full silicone versus Hydrogel coated latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Full silicone versus Siliconised latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number with burning sensation in urethra <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Silicone versus non‐silicone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number with urethritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Silicone versus latex</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number with meatal stricture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Latex (3 way catheter size 22G) versus PVC (3 way catheter size 22G)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">One type of standard catheter versus another standard catheter</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004013.pub4/references#CD004013-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004013.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004013-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004013-note-0007">فارسی</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004013\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004013\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004013\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004013\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004013\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZDBB8PHY&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004013.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004013.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004013.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004013.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004013.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714316490"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004013.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714316493"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004013.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6bb69b73f3cd',t:'MTc0MDcxNDMxNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 